<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NPG//DTD XML Article//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName NPG_XML_Article.dtd?>
<?SourceDTD.Version 2.7.10?>
<?ConverterInfo.XSLTName nature2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
    <journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
    <journal-title-group>
      <journal-title>Scientific Reports</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2045-2322</issn>
    <publisher>
      <publisher-name>Nature Publishing Group</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4764925</article-id>
    <article-id pub-id-type="pii">srep21383</article-id>
    <article-id pub-id-type="doi">10.1038/srep21383</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Crysalis: an integrated server for computational analysis and design of protein crystallization</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Huilin</given-names>
        </name>
        <xref ref-type="aff" rid="a1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Feng</surname>
          <given-names>Liubin</given-names>
        </name>
        <xref ref-type="aff" rid="a1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Ziding</given-names>
        </name>
        <xref ref-type="aff" rid="a2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Webb</surname>
          <given-names>Geoffrey I.</given-names>
        </name>
        <xref ref-type="aff" rid="a3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lin</surname>
          <given-names>Donghai</given-names>
        </name>
        <xref ref-type="corresp" rid="c1">a</xref>
        <xref ref-type="aff" rid="a1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Song</surname>
          <given-names>Jiangning</given-names>
        </name>
        <xref ref-type="corresp" rid="c2">b</xref>
        <xref ref-type="aff" rid="a3">3</xref>
        <xref ref-type="aff" rid="a4">4</xref>
        <xref ref-type="aff" rid="a5">5</xref>
      </contrib>
      <aff id="a1"><label>1</label><institution>Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University</institution>, Xiamen 361005, <country>China</country></aff>
      <aff id="a2"><label>2</label><institution>State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University</institution>, Beijing 100193, <country>China</country></aff>
      <aff id="a3"><label>3</label><institution>Monash Centre for Data Science, Faculty of Information Technology, Monash University</institution>, Melbourne, VIC 3800, <country>Australia</country></aff>
      <aff id="a4"><label>4</label><institution>Department of Microbiology, School of Biomedical Sciences, Monash University</institution>, Melbourne, VIC 3800, <country>Australia</country></aff>
      <aff id="a5"><label>5</label><institution>National Engineering Laboratory for Industrial Enzymes, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences</institution>, Tianjin 300308, <country>China</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="c1">
        <label>a</label>
        <email>dhlin@xmu.edu.cn</email>
      </corresp>
      <corresp id="c2">
        <label>b</label>
        <email>Jiangning.Song@monash.edu</email>
      </corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>24</day>
      <month>02</month>
      <year>2016</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2016</year>
    </pub-date>
    <volume>6</volume>
    <elocation-id>21383</elocation-id>
    <history>
      <date date-type="received">
        <day>12</day>
        <month>08</month>
        <year>2015</year>
      </date>
      <date date-type="accepted">
        <day>22</day>
        <month>01</month>
        <year>2016</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2016, Macmillan Publishers Limited</copyright-statement>
      <copyright-year>2016</copyright-year>
      <copyright-holder>Macmillan Publishers Limited</copyright-holder>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <!--author-paid-->
        <license-p>This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p>
      </license>
    </permissions>
    <abstract>
      <p>The failure of multi-step experimental procedures to yield diffraction-quality crystals is a major bottleneck in protein structure determination. Accordingly, several bioinformatics methods have been successfully developed and employed to select crystallizable proteins. Unfortunately, the majority of existing <italic>in silico</italic> methods only allow the prediction of crystallization propensity, seldom enabling computational design of protein mutants that can be targeted for enhancing protein crystallizability. Here, we present Crysalis, an integrated crystallization analysis tool that builds on support-vector regression (SVR) models to facilitate computational protein crystallization prediction, analysis, and design. More specifically, the functionality of this new tool includes: (1) rapid selection of target crystallizable proteins at the proteome level, (2) identification of site non-optimality for protein crystallization and systematic analysis of all potential single-point mutations that might enhance protein crystallization propensity, and (3) annotation of target protein based on predicted structural properties. We applied the design mode of Crysalis to identify site non-optimality for protein crystallization on a proteome-scale, focusing on proteins currently classified as non-crystallizable. Our results revealed that site non-optimality is based on biases related to residues, predicted structures, physicochemical properties, and sequence loci, which provides in-depth understanding of the features influencing protein crystallization. Crysalis is freely available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nmrcen.xmu.edu.cn/crysalis/">http://nmrcen.xmu.edu.cn/crysalis/</ext-link>.</p>
    </abstract>
  </article-meta>
</front>
<body>
  <p>Knowledge of protein 3D structures has significantly accelerated scientific discovery in many research areas, including protein biological function, drug screening and design, and human health and disease<xref ref-type="bibr" rid="b1">1</xref>. However, experimental efforts involving protein crystallization frequently fail during the multi-step procedures required to yield diffraction-quality crystals, achieving an overall success rate of only 2–10%<xref ref-type="bibr" rid="b2">2</xref>. In our recent work, we grouped five major experimental procedures, including sequence cloning failure (CLF), protein material production failure (MF), purification failure (PF), crystallization failure (CF), and ultimately structure determination (CRYs)<xref ref-type="bibr" rid="b3">3</xref>, and addressed the task of predicting protein crystallization propensity using machine-learning approaches to score each protein on its propensity to successfully pass each of the five steps in the crystallization pipeline. To surmount obstacles that arise from each procedure and accelerate the process, it is necessary to develop a systematic tool that can enable rapid prioritization and selection of appropriate target proteins from a large pool of candidates and allow the rational design of those targets with predicted lower crystallization propensity in order to enhance their crystallizability.</p>
  <p>A number of computational approaches have been developed to predict protein crystallization propensity for the purpose of target prioritization and selection using machine learning or statistical algorithms. The first set of computational methods, including SECRET<xref ref-type="bibr" rid="b4">4</xref>, CRYSTALP<xref ref-type="bibr" rid="b5">5</xref>, OBScore<xref ref-type="bibr" rid="b6">6</xref>, ParCrys<xref ref-type="bibr" rid="b7">7</xref>, CRYSTALP2<xref ref-type="bibr" rid="b8">8</xref>, MCSG-Z score<xref ref-type="bibr" rid="b9">9</xref>, and SCMCRYS<xref ref-type="bibr" rid="b10">10</xref>, adopted a number of sequence-derived features to train prediction models and achieved reasonable computational efficiency. However, when evaluated on an updated independent test dataset, almost all of these methods perform poorly<xref ref-type="bibr" rid="b3">3</xref>. To improve prediction performance, a second set of computational methods, including XtalPred<xref ref-type="bibr" rid="b11">11</xref>, Pxs<xref ref-type="bibr" rid="b12">12</xref>, SVMCRYS<xref ref-type="bibr" rid="b13">13</xref>, PPCPred<xref ref-type="bibr" rid="b2">2</xref>, XANNPred<xref ref-type="bibr" rid="b14">14</xref>, RFCRYS<xref ref-type="bibr" rid="b15">15</xref>, CRYSpred<xref ref-type="bibr" rid="b16">16</xref>, and XtalPred-RF<xref ref-type="bibr" rid="b17">17</xref>, utilize predicted structure information, such as predicted secondary structure, disordered segments, and solvent accessibility of residues. Nevertheless, most state-of-the-art methods, including PPCPred<xref ref-type="bibr" rid="b2">2</xref>, XtralPred-RF<xref ref-type="bibr" rid="b17">17</xref>, and PredPPCrys<xref ref-type="bibr" rid="b3">3</xref>, have computational inefficiencies that limit their capacity to select crystallizable target proteins at proteome-wide scale.</p>
  <p>It remains a significant challenge for structural genomics consortiums to crystalize and solve the 3D structures of proteins that possess important biological functions, but are difficult to crystalize<xref ref-type="bibr" rid="b1">1</xref><xref ref-type="bibr" rid="b18">18</xref>. It has become common practice for structural biologists to introduce one or more point mutations into the wild-type variant in order to generate protein mutants capable of being crystalized and refined<xref ref-type="bibr" rid="b19">19</xref><xref ref-type="bibr" rid="b20">20</xref>. This strategy is particularly helpful in overcoming obstacles that impede the crystallization of some target proteins, but often requires a trial-and-error approach, which is labor-intensive and time-consuming. Furthermore, the identification of candidate amino acids or regions that can be targeted for site-directed mutagenesis is non-trivial. As a useful alternative, bioinformatics tools can be used as a powerful method to enable rapid <italic>in silico</italic> screening and computational design of those target proteins that are predicted to have lower crystallization propensity. For example, computational methods that provide predictions concerning loops, disordered regions, and solvent-exposed hydrophobic segments/loops help to uncover a source of microheterogeneity that disfavors intermolecular interactions and impedes formation of well-ordered crystals<xref ref-type="bibr" rid="b20">20</xref><xref ref-type="bibr" rid="b21">21</xref>. Another computational method developed based on the concept of surface entropy reduction (SER) has significantly contributed to the crystallization and structure determination of 15 previously non-crystallizable proteins<xref ref-type="bibr" rid="b22">22</xref><xref ref-type="bibr" rid="b23">23</xref>.</p>
  <p>Here, we develop and implement a new machine learning-based bioinformatics tool called Crysalis, which not only provides rapid prediction of sequence-based protein crystallization propensity, but also enables users to computationally analyze and design protein mutants to further enhance their likelihood of successful crystallization. Crysalis is an updated version of PredPPCrys<xref ref-type="bibr" rid="b3">3</xref>. It adopts an integrated approach to predicting the propensity of a protein to pass each of the five steps CLF, MF, PF, CF, CRYs using multifaceted sequence-based features and adopting multi-step feature selection to assemble an optimal feature set for each prediction class. This method constructs two-level support-vector regression (SVR) models to estimate the propensity of five experimental procedures in X-ray crystallography-based protein structure determination. Based on the Crysalis prediction method, we further developed the Crysalis design method to facilitate computational engineering of non-crystallizable proteins and integrate a guide annotation of predicted target protein structure characteristics. To confirm Crysalis functions, we validated the Crysalis design method using both the datasets of currently non-crystallizable proteins and experimental protein mutations. In summary, Crysalis is a powerful tool for computational prioritization and the rational design of crystallizable protein targets.</p>
  <sec disp-level="1">
    <title>Results</title>
    <sec disp-level="2">
      <title>Multi-step feature selection</title>
      <p>We extracted a total of 4706 multifaceted sequenced-based features to investigate the most important characteristics that determinate the success of five procedures related to X-ray crystallography-based experiments. These feature sets can be categorized into four broad categories (see Methods), as the features based on amino acid composition (AAc), amino acid index (AAindex), k-spaced amino acid pairs (KSAAP), and grading KSAAP (GKSAAP). As described for PredPPCrys<xref ref-type="bibr" rid="b3">3</xref>, the AAindex-based features utilized 531 complete indices of 20 amino acids available in the current AAindex1 database<xref ref-type="bibr" rid="b24">24</xref>, which encode abundant physicochemical properties of the target protein<xref ref-type="bibr" rid="b3">3</xref><xref ref-type="bibr" rid="b24">24</xref> and display a high correlation coefficient. The KSAAP- and GKSAAP-based features are high-dimensional and high-correlation methods, and a large proportion of these features are irrelevant for the prediction task. Therefore, we performed first-step minimum-redundancy maximum-relevance (mRMR) feature selection on each AAindex-, KSAAP-, and GKSAAP-based feature set and ultimately selected 100 features for each feature group. Next, we performed the second-step mRMR feature selection to filter out other irrelevant/redundant features in the remaining set<xref ref-type="bibr" rid="b3">3</xref>. The feature distributions of four groups after two-step mRMR for five-class prediction are shown in <xref ref-type="table" rid="t1">Table 1</xref>.</p>
      <p>After the second-step feature selection using mRMR, we selected the top 100 features considering both maximum relevance and minimum redundancy for each prediction class. Subsequently, we adopted forward-feature selection (FFS)<xref ref-type="bibr" rid="b3">3</xref><xref ref-type="bibr" rid="b25">25</xref><xref ref-type="bibr" rid="b26">26</xref> to avoid over-fitting of machine-learning models and selected a subset of optimal features. The FFS process was performed using the benchmark training datasets with 5-fold cross-validation and the performances of the corresponding SVR models were evaluated via area under curve (AUC) scores. Ultimately, a smaller subset of the final optimal features for each experimental procedure was generated after the aforementioned multi-step feature selection (<xref ref-type="table" rid="t1">Table 1</xref>).</p>
      <p>Prediction performance of first-level Crysalis models based on benchmark datasets. As described in methods, Crysalis adopts a two-level approach, where the first level predicts a propensity score for each class and then the second level uses the scores for all classes as inputs to the final predictor for the each class. We evaluated the prediction performance of first-level Crysalis SVR models (Crysalis I) using the final optimal feature sets from the benchmark datasets via the 5-fold cross-validation tests. Finally, Crysalis I achieved AUC scores of 0.732, 0.767, 0.790, 0.737, and 0.773 for the prediction of CLF, MF, PF, CF, and CRYs, respectively. We compared the performance of first-level predictors between Crysalis and our previously developed method, PredPPCrys<xref ref-type="bibr" rid="b3">3</xref>, by assessing six different measures, including AUC, Matthew’s correlation coefficient (MCC), accuracy (ACC), specificity (SPE), sensitivity (SEN), and precision (PRE). The first-level Crysalis SVR predictor performed better than PredPPCrys in terms of the AUC, ACC, and MCC measurements (<xref ref-type="table" rid="t2">Table 2</xref>), except for the MF class.</p>
    </sec>
    <sec disp-level="2">
      <title>Feature importance and contribution</title>
      <p>As described, a small subset of the final optimal features was generated following multi-step feature selection, constituting 25, 78, 95, 68, and 65 features in the final selected feature set for the classes of CLF, MF, PF, CF, and CRYs, respectively (<xref ref-type="table" rid="t1">Table 1</xref>). We analyzed the contributing and determinant effects of the optimal selected features on the performance of first-level Crysalis SVR predictors. It is evident that the major contributing features are GKSAAP-, KSAAP-, and AAindex-based feature sets based on the results of the feature distribution in the final optimal feature set (<xref ref-type="table" rid="t1">Table 1</xref>).</p>
      <p>Our method distinguishes itself from previous methods in its use of features based on both KSAAP and GKSAAP. Previous studies clarified that the frequency of amino acid pairs is important for protein crystallization prediction<xref ref-type="bibr" rid="b5">5</xref><xref ref-type="bibr" rid="b10">10</xref>. Our experimental results indicate that the KSAAP-based feature group is another dominating feature set in the final optimal features of all five-class predictions, which agrees with those studies. KSAAP composition was first proposed by Chen <italic>et al.</italic><xref ref-type="bibr" rid="b27">27</xref>. Given its significant improvement in sequence-based model performance, the KSAAP encoding scheme has been widely used in a number of bioinformatics studies, such as predictions of flexible/rigid regions<xref ref-type="bibr" rid="b27">27</xref>, O-glycosylation sites<xref ref-type="bibr" rid="b28">28</xref>, ubiquitination sites<xref ref-type="bibr" rid="b29">29</xref><xref ref-type="bibr" rid="b30">30</xref>, protein phosphorylation sites<xref ref-type="bibr" rid="b31">31</xref>, etc. Nevertheless, for a sequence consisting of 200 amino acids, the average value of all amino acid pairs for KSAAP encoding is only ~0.5. As a result, most amino acid pairs would have little or no statistical significance. Additionally, many amino acid pairs exhibit similar physicochemical properties (e.g. the amino acid pairs KD and RD have similar properties in terms of ion pairs). Accordingly, it is difficult for the KSAAP feature to fully describe and capture all useful information for those similar amino acid pairs. To address this issue, we separated all 20 amino acids into three classes based on their physicochemical properties. Specifically, six significant physicochemical characteristics were graded and applied based on accessible surface area, side-chain orientation, charge, hydrogen-bond donor, hydrophobicity, and van der Waals potential. Importantly, the GKSAAP feature is a new, informative feature developed in this study and plays a role in the predictions of MF and CRYs, resulting in a larger number of final selected features for these two classes. Feature selection results suggest that GKSAAP is a useful feature for the prediction of protein crystallizability (the classes of MF, PF, and CRYs), possibly due to its advantage when capturing useful information involving protein characteristics. Compared with the KSAAP encoding scheme, the novel GKSAAP scheme takes into consideration grading amino acid pairs, not only incorporating pairs that possess similar properties, but also extracting their multifaceted physicochemical properties, rather than those of the individual 20 amino acids.</p>
      <p>Previous methods for protein crystallization prediction, such as PPCPred<xref ref-type="bibr" rid="b2">2</xref>, CRYSPred<xref ref-type="bibr" rid="b16">16</xref>, and PredPPCrys<xref ref-type="bibr" rid="b3">3</xref>, used the AAindex-based feature as one of most important feature types. Our Crysalis results were similar to those from other methods and the final optimal feature sets of MF, PF, and CRYs classes contained a number of AAindex-based features. Additionally, other contributing features included composition of tripeptides and the 20 standard amino acids. Details of the final optimal feature set for each class can be found in the <xref ref-type="supplementary-material" rid="S1">supplementary files</xref> at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nmrcen.xmu.edu.cn/crysalis/Datasets.html">http://nmrcen.xmu.edu.cn/crysalis/Datasets.html</ext-link>.</p>
      <p>We proceeded to evaluate the importance and contribution of the four feature types for each prediction class. First, we examined the influence of iteratively performing each feature type on AUC-based prediction performance by removing this feature type from the final feature set. Furthermore, we analyzed the performance contribution of each feature type on all of the five-class predictions by applying the individual feature types in the optimal feature set. The results are shown in <xref ref-type="fig" rid="f1">Fig. 1</xref>. For CRYs prediction, the important order of the four feature types was AAindex, GKSAAP, KSAAP, and AAc, with AUCs of 0.748, 0.687, 0.579, and 0.522, respectively. For MF prediction, the GKSAAP is the least important feature type contributing to the optimal prediction model. GKSAAP was used to successfully predict PF propensity, resulting in an AUC of 0.737. However, Crysalis did not select any feature-based GKSAAP encoding as a component part of the optimal feature set for the CLF and CF classes. Contrastingly, KSAAP played a decisive role in SVR-model training for those two classes. The importance of KSAAP on the CF class was reflected by the large decrease in AUC scores (from 0.762 to 0.500) when we used the remaining features to train SVR models. It is evident that AAindex-based features are important for the CLF, MF, PF, and CRYs prediction classes.</p>
      <p>In summary, this study developed a new feature-encoding method called GKSAAP and found that it played an important role in the prediction of multi-experimental procedures during X-ray crystallography-based structure determination. We hope that this new feature-encoding method can be widely applied to other structural bioinformatics research. A complex subset consisting of four different kinds of feature types was finally selected by multi-step feature selection, which made the prediction models more accurate and robust, except for the CF class. The importance and contribution of the four feature types used in the final feature set can help us understand the process of protein crystallization and enhance protein crystallizability by engineering suitable features in target proteins.</p>
    </sec>
    <sec disp-level="2">
      <title>Performance improvement based on implementation of second-level SVR predictors</title>
      <p>Our previous PredPPCrys<xref ref-type="bibr" rid="b3">3</xref> demonstrated successful probability outputs for each experimental procedure generated by first-level predictors. The five outcomes CLF, MF, PF, CF, and CRYs form a cascade such that each is correlated with the previous outcomes have been passed or not<xref ref-type="bibr" rid="b3">3</xref>. For this reason, we also built a second-level SVR predictor (Crysalis II) using five probability outputs from the first-level SVR predictor (Crysalis I) as input features. Crysalis II displayed improvements in performance across all five classes, with improved AUC scores from 0.731 to 0.759, 0.772 to 0.793, 0.796 to 0.801, 0.739 to 0.752, and 0.788 to 0.838 for the classes CLF, MF, PF, CF, and CRYs, respectively. In order to improve SVR-model performance, we optimized all SVR models from both Crysalis I and II using three available kernel types (sigmoid, radial-basis function, and polynomial) with a grid search of two kernel parameters (<italic>C</italic> and γ).</p>
    </sec>
    <sec disp-level="2">
      <title>Performance comparison with other methods</title>
      <p>To benchmark the predictive performance of Crysalis, we compared its performance with the three most recently developed tools (PredPPCrys<xref ref-type="bibr" rid="b3">3</xref>, PPCPred<xref ref-type="bibr" rid="b2">2</xref>, and XtalPred-RF<xref ref-type="bibr" rid="b17">17</xref>), as well as other existing methods (ParCrys<xref ref-type="bibr" rid="b7">7</xref>, OBScore<xref ref-type="bibr" rid="b6">6</xref>, CRYSTAP2<xref ref-type="bibr" rid="b8">8</xref>, XtalPred<xref ref-type="bibr" rid="b11">11</xref>, and SVMCRYs<xref ref-type="bibr" rid="b13">13</xref>), using previously published independent test datasets<xref ref-type="bibr" rid="b3">3</xref>. The performance of all predictors was evaluated using AUC, MCC, ACC, SPE, SEN, and PRE measurements and the results are summarized in <xref ref-type="table" rid="t3">Table 3</xref>. It should be noted that PredPPCrys<xref ref-type="bibr" rid="b3">3</xref> and Crysalis were able to predict five-class experimental procedures. Most tools can only predict protein crystallization, but not for all experimental procedures, with the exception of PPCPred<xref ref-type="bibr" rid="b2">2</xref>, which is capable of four-class prediction. Therefore, we compared Crysalis to the tools capable of providing valid predictions for the procedures of interest. Ultimately, Crysalis achieved AUC scores of 0.759, 0.793, 0.801, 0.752, and 0.838 for the five-class experimental procedures of CLF, MF, PF, CF, and CRYs, respectively.</p>
      <p>Most tools focus on predicting the propensity of a sequence to yield CRYs. Therefore, we analyzed and compared this prediction class. The binary classification-based prediction methods for protein crystallizability, including XtalPred, SVMCRYs, XtalPred-RF, and SCMCRYS, were primarily evaluated using MCC scores. They achieved MCC values of 0.244, 0.142, 0.205, and 0.145, respectively, which were lower than those achieved by Crysalis (MCC = 0.435). The real-valued propensity-based prediction method is more robust when performed on the updated datasets than those based on binary classification, given the importance of estimating the difficulty (or successful propensity) of a sequence to yield diffraction-quality crystals. Additionally, some current non-crystallizable proteins may become crystallizable using new protein crystallization technologies in the future<xref ref-type="bibr" rid="b2">2</xref><xref ref-type="bibr" rid="b3">3</xref>. Our previous tool, PredPPCrys<xref ref-type="bibr" rid="b3">3</xref>, and Crysalis are real-valued propensity-based predictors and outperform existing tools, including ParCrys<xref ref-type="bibr" rid="b7">7</xref>, OBscore<xref ref-type="bibr" rid="b6">6</xref>, CRYSTAP2<xref ref-type="bibr" rid="b8">8</xref>, and PPCPred<xref ref-type="bibr" rid="b2">2</xref>.</p>
      <p>PPCPred<xref ref-type="bibr" rid="b2">2</xref> first introduced four experimental-step predictions and is a SVM-based tool that utilizes comprehensive sets of 36 AAindex-based and sequence-derived predicted structural features (predicted disorder, secondary structure, and solvent accessibility) to estimate protein crystallization propensity<xref ref-type="bibr" rid="b2">2</xref>. Crysalis outperformed PPCPred<xref ref-type="bibr" rid="b2">2</xref> for all four-class experimental procedures, with improvements in prediction performance. Most recently, PredPPCrys<xref ref-type="bibr" rid="b3">3</xref> distinguished the process of protein crystallization into five-class procedures by adding the initial class of sequence cloning; these datasets were used in this study. PredPPCrys<xref ref-type="bibr" rid="b3">3</xref> adopted a comprehensive set of multifaceted sequence-derived features (amino acid types, compositions, physiochemical properties, predicted structural features, protein features generated from an online web server (PROFEAT)<xref ref-type="bibr" rid="b32">32</xref>, and multifaceted feature combinations) in combination with a novel multi-step feature-selection strategy to build two-level SVM predictors. Compared to PredPPCrys<xref ref-type="bibr" rid="b3">3</xref>, Crysalis integrated four sequence-based feature groups, resulting in both high prediction performance and computational efficiency. Results of the independent test show that Crysalis outperformed PredPPCrys<xref ref-type="bibr" rid="b3">3</xref> for the classes of CLF and CF, and displayed higher scores for the classes of CLF and CRYs. For PF prediction, Crysalis performance was lower than that of PredPPCrys<xref ref-type="bibr" rid="b3">3</xref>. However, another advantage of Crysalis is its computational efficiency as compared to three state-of-the-art methods (PPCPred<xref ref-type="bibr" rid="b2">2</xref>, XtalPred-RF<xref ref-type="bibr" rid="b17">17</xref>, and PredPPCrys<xref ref-type="bibr" rid="b3">3</xref>). Its turnaround time for a prediction task (&lt;1s) is significantly shorter than that of all three tools, suggesting a 50-fold speed improvement (PredPPCrys<xref ref-type="bibr" rid="b3">3</xref>, PPCPred<xref ref-type="bibr" rid="b2">2</xref>, and XtalPred-RF<xref ref-type="bibr" rid="b17">17</xref> required an average of 196, 153, and 84 s, respectively, for completing a protein analysis). Based on these results, Crysalis is more suitable for proteome-wide target selection for protein crystallization and may be applied to develop an analysis tool aimed at computational design by examining the propensity changes associated with target-protein mutations<xref ref-type="bibr" rid="b33">33</xref>.</p>
    </sec>
    <sec disp-level="2">
      <title>Crysalis web server implementation</title>
      <p>Crysalis has two built-in modes that support and communicate with each other, i.e. the prediction mode and design mode (<xref ref-type="fig" rid="f2">Fig. 2B</xref>). Two models are used for rapid target selection and computational design, respectively. Examples of its usage and outputs can be found at our website <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nmrcen.xmu.edu.cn/crysalis/FAQ.html">http://nmrcen.xmu.edu.cn/crysalis/FAQ.html</ext-link>. We briefly discuss these two modes in the following sections.</p>
    </sec>
    <sec disp-level="2">
      <title>Prediction mode</title>
      <p>The purpose of the prediction mode is to predict the propensity of a target protein to successfully undergo multi-step experimental crystallization procedures based on its amino acid sequence, comprising two-level SVR results (Crysalis I and Crysalis II). It is noteworthy that users can run a batch job (up to 10,000 proteins allowed) to predict the propensity of the target protein to successfully pass any of the five major experimental steps. A typical batch prediction task will require ~10 min before returning prediction results of 5,000 sequences.</p>
    </sec>
    <sec disp-level="2">
      <title>Design mode</title>
      <p>The design mode improves the experimental design of those target proteins predicted by Crysalis with a lower propensity score, enabling it to pass a particular experimental procedure for successful crystallization, and ultimately, determination of its structure. Hence, the design mode may be seen as a complementary module to the prediction mode, enabling users to improve crystallization success rates by focusing on the designed mutants with enhanced propensity rather than the wild-type. In design mode, a number of possible single-point mutations are introduced and their corresponding crystallizability scores are estimated by applying regression models from the prediction mode. As a result, Crysalis is able to generate a comprehensive list of designed (or prioritized) mutants for a target protein ranked and annotated with their corresponding propensity scores. The design mode takes Crysalis 5–25 min to comprehensively analyze and return the results of a query sequence, with the computational time primarily depending on amino-acid sequence length. Moreover, the design mode allows users to submit a query for a target protein of interest, returning three resulting outputs:</p>
    </sec>
    <sec disp-level="2">
      <title>Prediction results</title>
      <p>The results of protein crystallizability propensities include two-level scores generated by level-1 and level-2 SVR models of the five-class experimental procedures. The results are informative and helpful in estimating protein crystallizability propensity for the wild-type target protein and identifying which experimental procedure(s) might fail in the experimental efforts.</p>
    </sec>
    <sec disp-level="2">
      <title>Computational design results</title>
      <p>The results of all recommended protein mutants that are predicted to enhance protein crystallizability propensity following single-point mutation are available for download at the Crysalis website as either residue- or score-based result files. Additionally, this is useful for identifying candidate residues (or sites) whose mutation is potentially helpful for improving protein crystallizability. These results are shown and highlighted as a hotspot map of site non-optimality, where red-colored residues represent candidate sites whose mutation is predicted to be potentially helpful for enhancing protein crystallization propensity. Note that only 20 recommended prioritized mutations will be shown at the output web page, while a comprehensive list of all recommended mutants (in order of increasing predicted propensity scores) can be downloaded as an additional file for follow-up investigations.</p>
    </sec>
    <sec disp-level="2">
      <title>Complementary functional annotations</title>
      <p>To facilitate choosing plausible target protein mutants, the Crysalis server integrates and outputs target protein functional annotations, including transmembrane regions, secondary structure, predicted natively-disordered regions, residue solvent accessibility (in terms of exposed or buried status), functional domains (beginning and ending positions), and conserved residues inferred from multiple sequence alignments. Point mutations that occur within a functional domain or those predicted to interrupt functional sites would be disfavored as compared to other mutation options localized outside functional domain regions. These functional annotations are expected to facilitate selection of mutants and hypothesis-driven experimental analysis.</p>
    </sec>
    <sec disp-level="2">
      <title>Complementary functional annotation and analysis of target proteins by Crysalis</title>
      <p>Crysalis also provides complementary target protein functional features and annotations (previously detailed), which enable investigation of sequence-structure-function relationships for the purpose of analyzing, designing, and selecting suitable mutations for protein crystallizability. To examine the relationship between structural properties of residues and protein crystallizability, we analyzed site non-optimality (i.e. <italic>C</italic><sub>i</sub>, see Methods) of a proteome-scale dataset (the independent CRYs test dataset) with respect to secondary-structure types, disorder/order, buried/exposed status, side-chain entropy, charged amino acids, hydrophobicity, and sequence loci (<xref ref-type="table" rid="t4">Table 4</xref>). Our results revealed that residues in three different secondary-structure types did not display statistical significance relative to site non-optimality; however, residues predicted to be disordered exhibited stronger non-optimality than those predicted to be ordered (<italic>C</italic><sub>i</sub> &gt; 0.2 category, 1.64% vs. 0.19%). We also observed that exposed residues have a greater tendency (0.46% vs. 0.23%) to be targets of mutation, consistent with the expectation that protein engineering experiments usually involve exposed residues, owing to disfavored intermolecular interactions caused by exposed amino acids. However, side-chain entropy reduction has proven to be a powerful strategy for protein crystallization design<xref ref-type="bibr" rid="b22">22</xref>. Here, our results indicate that the majority of residues with higher conformational entropy (KQE) tend to be located at the protein surface and appear to be non-optimal as compared to those buried. Additionally, amino acid charge is another important factor than might influence protein crystallization. We found that residues C, H, N, and R constitute the most ‘designable’ options (<xref ref-type="table" rid="t5">Table 5</xref>). Specifically, C is often an influencing factor in protein microheterogeneity due to its role in forming incorrect inter- and intra-disulfide bonds. Notably, in terms of the sequence loci, both N-terminal and C-terminal regions (with a length of 20 amino acids) are more amenable to alteration toward the design of protein crystallizability as compared to intermediate regions (0.90% and 2.75%, respectively, vs. 0.14%). This raises the possibility of developing a truncated expression-based experimental strategy for enhancing protein crystallizability.</p>
    </sec>
    <sec disp-level="2">
      <title>Design mode experimental validation</title>
      <p>We tested the Crysalis design mode on a proteome-scale protein mutation dataset (<italic>Mut</italic>) recently annotated and extracted from TargetTrack (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://sbkb.org/">http://sbkb.org/</ext-link>). The <italic>Mut</italic> dataset includes 11,946 target proteins with 32,126 experimental trials, with each target protein comprised of a wild-type trial and one or more mutations. We applied prediction models to estimate alterations in protein crystallizability, following the incorporation of specific mutations. More specifically, Crysalis predicted the differences in crystallizability propensity between the mutations and the wild-type variant using the Crysalis CRYs prediction model. We only considered a set of targets whose wild-type structure was predicted to be non-crystallizable (score &lt; 0.5). Finally, Crysalis displayed 75.1% accuracy in correctly predicting that the probability change associated with specific mutations was computed as a positive value (<inline-formula id="d33e537"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e538" xlink:href="srep21383-m1.jpg"/></inline-formula>). These results suggest that Crysalis could be used in the prediction and computational design of protein crystallization and could be specifically applied to promote engineering target-proteins to enable the crystallization of predicted non-crystallizable proteins.</p>
    </sec>
    <sec disp-level="2">
      <title>Case study</title>
      <p>In this section, we provide a case study comprising two application examples to further illustrate the prediction and design utility of the Crysalis webserver.</p>
      <p>The target protein enoyl-CoA hydratase/isomerase from <italic>Acinetobacter</italic> sp. ADP1 (NCBI sequence name YP_047189.1 in TargetTrack NYSGXRC-11252j) was non-crystallizable annotated with the status of ‘cloned’ in the database. Crysalis II predicted that the procedures of CLF, MF, CF and CRYs had propensity scores of 0.426, 0.283, 0.471 and 0.484, respectively. To improve protein crystallizability, we further performed a target selection for this protein by applying Crysalis to estimate the protein crystallizability changes of candidate proteins. 100 candidate proteins with a sequence identity of &gt;76% along with an successful experimental example were downloaded from the NCBI Reference Sequence<xref ref-type="bibr" rid="b34">34</xref>, with the batch prediction results available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nmrcen.xmu.edu.cn/crysalis/prediction/Result_344.html">http://nmrcen.xmu.edu.cn/crysalis/prediction/Result_344.html</ext-link>. The results suggest that several candidate proteins were predicted to have greater crystallizability than the original YP_047189.1, which can be used for structural determination of the representative 3-D structure of this protein family. In addition, the experimental results provided by TargetTrack show that if the target sequence was replaced by its homologous protein modified from <italic>Acinetobacter baumannii</italic> (NCBI sequence name: WP_004885783) with a sequence identity of 78%, diffraction-quality crystals (PDB entry: 3FDU) would be successfully yielded. Crysalis II predicted that the corresponding propensities of the experimental procedures of this modified protein were 0.551, 0.572, 0.584, and 0.527 for CLF, MF, CF, and CRYs, respectively, which is in a good agreement with the experimental results.</p>
      <p>As another example, the nucleoside-diphosphate-sugar pyrophosphorylase from <italic>Vibrio cholerae</italic> RC9 (TargetTrack name: VcR193) was annotated as non-crystallizable with the status of ‘purified’ in the TargetTrack database. Crysalis I accurately predicted that both procedures of PF and CRYs failed with the predicted propensities of 0.236 and 0.468, respectively. Mutagenesis experiments indicate that three single mutations A42R, V122R, and L211E can improve protein crystallizability, reaching 0.238 and 0.473 for the A42R mutant (‘crystalized’), 0.237 and 0.463 for the V122R mutant (‘crystalized’), 0.239 and 0.475 for the L211E mutant (‘diffraction-quality crystal’, PDB entry: 4EVW), respectively. In this case, although the predicted scores of the three mutants were still lower than the cut-off value of 0.5, the crystallizability improvement has led to the successful production of crystals or diffraction-quality crystals. We further applied the Crysalis design mode to analyze the amino acid sequence of this protein. The results show that the propensity changes of CRYs for the A42R, V122R and L211E mutants were 0.005, −0.005 and 0.007, respectively, while their propensity changes of PF were 0.002, 0.001 and 0.003, respectively. The ranking of propensity change CRYs for the L211E mutant was 594/4826, suggesting that a large set of single mutations might be used to further improve its protein crystallizability. The L211E mutation seems to play an important role in stabilizing its 3D structure through the binding of Mg<xref ref-type="bibr" rid="b2">2</xref><sup>+</sup> (<xref ref-type="supplementary-material" rid="S1">Supplementary Fig. S1</xref>), which might be a beneficial factor for improved protein crystallization. In summary, the two examples can serve as a useful guide for users to prioritize optimal targets from its homologous proteins using both the prediction and design modes of Crysalis. However, as the first machine learning algorithm-based tool developed for protein crystallizability design, Crysalis still has certain limitations and can be further improved.</p>
    </sec>
  </sec>
  <sec disp-level="1">
    <title>Discussion</title>
    <p>A brief review of existing methods for protein crystallization prediction suggests that corresponding machine-learning models exhibit contradictory relationships between prediction performance and computational efficiency. Methods designed to use only sequence-based features achieve reasonable computational efficiency (second scale), but consistently result in poor model performance. However, many recent approaches integrate sequence-derived structure prediction features to train their model, allowing for more accurate prediction performance despite the computational cost (minute scale). Therefore, previous methods appear unsuited for application towards computational design for protein crystallizability, wherein the predictor is required to test propensity changes associated with all probable single-point mutations. Studies indicate that these methods exhibit poor prediction performance and/or computational efficiency. Furthermore, binary classification-based tools, such as XtalPred-RF<xref ref-type="bibr" rid="b17">17</xref>, cannot report changes in the real-valued propensity that may occur between wild-type and incorporated mutations, making it unsuitable for the computational design of potential mutations.</p>
    <p>Here, we developed Crysalis, a novel <italic>in silico</italic> design method for protein crystallizability, based on machine learning. More specifically, Crysalis is able to estimate the propensities of the five major experimental procedures required by X-ray crystallography-based structure determination, which include CLF, MF, PF, CF and CRYs. In particular, the predictors of CLF could be used to predict the propensity for a target protein sequence to be successfully cloned from the original source of DNA. In general, problematic sequences often have high G+C contents, codon bias and/or complex intron/exon structures<xref ref-type="bibr" rid="b35">35</xref><xref ref-type="bibr" rid="b36">36</xref>. Nevertheless, as a fast and economically efficient technique, well-established gene synthesis has been widely applied, including optimization of codon bias, translation efficiency and oligonucleotide structure for expression in an organism of interest<xref ref-type="bibr" rid="b35">35</xref><xref ref-type="bibr" rid="b37">37</xref>. As a result, sequence cloning nowadays is often not considered as a major bottleneck for experimental studies. In this regard, if a cloning failure is predicted for a sequence, gene synthesis may be used as an alternative method.</p>
    <p>Crysalis utilizes a variety of useful and multifaceted sequence features in combination with a novel GKSAAP-based feature type, further refined to yield a smaller subset of optimal features for each class following multi-step feature selection. This method builds accurate two-level SVR models of five major experimental procedures, facilitating the prediction of real-valued propensities for these procedures. Our method distinguishes itself from previous methods by its increased computational efficiency, as well as its superior or comparable performance to state-of-the-art prediction tools for protein crystallization propensity. Therefore, Crysalis can be used for the selection of crystallizable proteins from a large pool of candidates on a proteome scale. Furthermore, Crysalis SVR models enable the estimation of propensity changes in protein crystallizability associated with all probable single-point mutations, which aids target protein engineering. Previous methods based on the concept of SER<xref ref-type="bibr" rid="b22">22</xref><xref ref-type="bibr" rid="b23">23</xref> only discover/resolve one aspect related to protein crystallization failure. Contrastingly, Crysalis designs target-protein mutations according to multifaceted protein features that can be used to resolve different issues that might result in failure to yield diffraction-quality crystals. We validated our design model on a proteome-scale, using proteins currently classified as non-crystallizable, and the results revealed that site non-optimality related to protein crystallization involves biases associated with disorder, solvent-exposed regions, SER, charge, or C-/N-terminal localization. These results are consistent with protein engineering methods employed by experimentalists and the SER concept.</p>
    <p>To promote further investigation, the Crysalis design mode integrates several bioinformatics tools to annotate predicted secondary structure elements, residue solvent accessibility, disordered regions, transmembrane regions, functional domains, and conserved sites. Protein crystallization is a complicated process involving several experimental procedures, any of which can result in experimental failure. Crysalis addresses these issues by concentrating on the propensity prediction and computational design of five experimental procedures. Finally, we showed that Crysalis can be applied to the computational engineering of protein crystallizability through proteome-scale validation of experimental mutations recently extracted from TargetTrack. Moreover, a user-friendly web server for target selection (prediction mode) and computational design (design mode) for protein crystallization experiments has been made available. We anticipate that Crysalis will be a powerful tool enabling protein engineering to enhance protein crystallizability, which may accelerate experimental studies and help to determine the crystal structures of biologically important proteins.</p>
  </sec>
  <sec disp-level="1">
    <title>Methods</title>
    <sec disp-level="2">
      <title>Datasets</title>
      <p>The benchmark datasets used in this study were created during the course of previous PredPPCrys work<xref ref-type="bibr" rid="b3">3</xref> and extracted from the PepcDB website (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://sg.pdb.org">http://sg.pdb.org</ext-link>)<xref ref-type="bibr" rid="b38">38</xref>, currently named TargetTrack (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sbkb.org/tt/">http://www.sbkb.org/tt/</ext-link>). The datasets provide five class assignments in terms of experimental crystallization failure or success for the included target proteins, including CLF, MF, PF, CF, and CRYs. Crysalis was developed using the SVR algorithm, its performance evaluated using the benchmark datasets, and further tested using independent test datasets.</p>
      <p>In order to evaluate the performance of our design models, we downloaded the most recent experimental datasets from TargetTrack (April 25, 2015), comprising 94,605 protein targets and 944,479 experimental trials. Each target consists of several experimental trials with each trial defined as an objective crystallization trial representing a set of experimental procedures used to crystallize the target<xref ref-type="bibr" rid="b3">3</xref>. This validation <italic>Mut</italic> dataset was extracted and selected according to the following criteria: (1) The most recent and advanced experimental status was annotated and used for each target. The statuses were grouped into procedures: selected (‘other’, ‘test target’, and ‘selected’), cloned (‘cloned’, ‘biological assay’, ‘biophysical analysis’, and ‘expression tested’), expressed (‘expressed’), soluble (‘soluble’ and ‘membrane protein solubilized’), purified (‘purified’), crystallized (‘crystallized’) and diffraction-quality crystals (‘diffraction-quality crystals’, ‘crystal structure’ and ‘in PDB’). (2) We only collected X-ray crystallography-based experimental trials. (3) To accurately estimate changes in experimental status, we only selected trials with a status of ‘cloned’ or higher. We then removed targets comprising only one experimental trial, because those targets did not contain any mutations in the TargetTrack database. (4) We collected the final status of all trials for each target and selected the target comprising multiple statuses. (5) We randomly assigned the lowest trial as the wild-type variant of the target and removed the trials sharing the same status or protein sequence as the wild-type. (6) Each target contained a trial consisting of the wild-type variant and several mutations (other trials) that promote protein crystallizability. In summary, there are 11,946 target proteins and 32,126 experimental trials (11,946 wild-type proteins and 20,180 mutations) in the <italic>Mut</italic> dataset. This resulted in an average of 1.67 mutations for each target protein. The <italic>Mut</italic> dataset is available at the website <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nmrcen.xmu.edu.cn/crysalis/Datasets.html">http://nmrcen.xmu.edu.cn/crysalis/Datasets.html</ext-link>.</p>
    </sec>
    <sec disp-level="2">
      <title>Feature extraction</title>
      <p>Crysalis extracts a comprehensive set of sequence-derived features (4706 features) as candidate features grouped into four main feature types: AAc, AAindex, KSAAP, and GKSAAP. The features used in this study are briefly discussed below:</p>
    </sec>
    <sec disp-level="2">
      <title>AAc-based features include the following 89 features</title>
      <p>(i) frequencies of 20 standard amino acids (20 features); frequencies of hydrophobic (F,I,W,L,V,M,Y,C,A), hydrophilic (R,K,N,D,E,P), neutral (T,H,G,S,Q), positively-charged (K,H,R), and negative-charged (D,E), amino acids summarized over the whole sequence (5 features); frequencies of tripeptides with the subgroup of hydrophobic, hydrophilic, and neutral properties (3 × 3 × 3 = 27 features); frequencies of tripeptides with the subgroup of positively-, negatively-, and neutrally-charged properties (3 × 3 × 3 = 27 features); frequencies of 10 residue types based on the chemical groups of their side chains. The 10 chemical groups include phenyl (F,W,Y), carboxyl (D,E), imidazole (H), primary amine (K), guanidine (R), thiol (C), sulfur (M), amido (Q,N), hydroxyl (S,T), and nonpolar (A,G,I,L,V,P) (10 features)<xref ref-type="bibr" rid="b13">13</xref>.</p>
    </sec>
    <sec disp-level="2">
      <title>AAindex-based features: (531 features)</title>
      <p>We used the AAindex1 indices from the AAindex database<xref ref-type="bibr" rid="b24">24</xref> to encode the physicochemical properties of 20 standard amino acids and subsequently computed average physicochemical properties over the entire sequence. Finally, we generated a total of 531 features based on the complete indices from AAindex1.</p>
    </sec>
    <sec disp-level="2">
      <title>KSAAP features: (3600 features)</title>
      <p>The KSAAP composition developed by Chen <italic>et al.</italic><xref ref-type="bibr" rid="b27">27</xref> was used in this study. For this scheme, the amino acid pairs of 20 standard amino acids include 400 (20 × 20) dimensional features. Moreover, different KSAAPs are also considered, including <italic>k</italic> = 0, 1, 2, 3, and 4 for computing KSAAP features. Additionally, we summarized amino acid pairs whose distance is less than a given <italic>k</italic> (1, 2, 3, or 4). For example, if <italic>k</italic> = 3, then the statistical amino acid pairs would comprise all amino acid pairs of KSAAP<sub>k = 0</sub>, KSAAP<sub>k = 1</sub>, KSAAP<sub>k = 2</sub>, and KSAAP<sub>k = 3</sub>.</p>
    </sec>
    <sec disp-level="2">
      <title>GKSAAP features: (486 features)</title>
      <p>For GKSAAP computing, the 20 amino acids were grouped into three classes: low (−1), middle (0), and high (+1), according to the relative physicochemical properties. For example, we can classify the 20 amino acids as negative (low), neutral (middle), or positive (high). More specifically, the following equation is used to classify the 20 amino acids into three groups:</p>
      <p>
        <disp-formula id="eq2">
          <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e683" xlink:href="srep21383-m2.jpg"/>
        </disp-formula>
      </p>
      <p>where <inline-formula id="d33e686"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e687" xlink:href="srep21383-m3.jpg"/></inline-formula> is a grading score of the amino acid <italic>i</italic> (<italic>AA</italic><sub>i</sub>), for the property <italic>n</italic>, <inline-formula id="d33e700"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e701" xlink:href="srep21383-m4.jpg"/></inline-formula> is the numeric value of the property, <italic>n</italic>, of the amino acid <italic>AA</italic><sub>i</sub>, <inline-formula id="d33e712"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e713" xlink:href="srep21383-m5.jpg"/></inline-formula> and <inline-formula id="d33e715"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e716" xlink:href="srep21383-m6.jpg"/></inline-formula> are the low and high cutoffs of the property <italic>n</italic>, respectively. Crysalis takes into account six different types of physiochemical properties, classifying the 20 amino acids into three corresponding subgroups based on their respective types and further encoded the GKSAAP features by varying <italic>k</italic> from 0 to 4. Classification of the 20 amino acids according to the six different types of physiochemical properties is shown in <xref ref-type="table" rid="t6">Table 6</xref>. Similar to the KSAAP scheme, we also summarized grading amino acid pairs whose distance is less than a given <italic>k</italic>. Finally, 486 features were generated by the GKSAAP encoding scheme, which is proposed for the first time in the present study and encodes nine GKSAAP features for each <italic>k</italic>.</p>
    </sec>
    <sec disp-level="2">
      <title>Crysalis architecture</title>
      <p>Crysalis includes a prediction mode and design mode, which support the crystallization propensity prediction and computational design of a target protein, respectively. We describe these two modes in the following two sections.</p>
    </sec>
    <sec disp-level="2">
      <title>Prediction mode</title>
      <p>The purpose of the prediction mode is to predict the propensity of a target protein to successfully undergo multi-step experimental procedures based on its amino acid sequence. To address this, we built five classification models to predict the sequence cloning, protein production, purification, and crystallization failure/success propensities, denoted as CLF, MF, PF, CF, and CRYS, respectively<xref ref-type="bibr" rid="b3">3</xref>. A schematic illustration of the Crysalis prediction mode is presented in <xref ref-type="fig" rid="f2">Fig. 2A</xref>. After extracting a large set of sequence-derived features, we employed a multi-step feature-selection algorithm to select subsets of optimal features for the prediction of each experimental class. In first-step feature selection, we used the mRMR method<xref ref-type="bibr" rid="b39">39</xref> to remove redundant and irrelevant features from each feature group of AAindex-, KSAAP- and GKSAAP-based features, and selected the top 100 contributory features for each feature group. In second-step feature selection, we performed the second-step mRMR feature selection on the combining feature sets of the selected 100 AAindex-, KSAAP-, and GKSAAP-based features after first-step feature selection and the remaining set (AAc-based features). In the third-step feature selection, the FFS method<xref ref-type="bibr" rid="b3">3</xref><xref ref-type="bibr" rid="b25">25</xref><xref ref-type="bibr" rid="b26">26</xref> was used to select an optimal subset of the best-performing features via 5-fold cross-validation. Finally, 25, 78, 95, 68, and 65 optimal features were selected for training the SVR models of CLF, MF, PF, CF and CRYs, respectively. Similar to PredPPCrys<xref ref-type="bibr" rid="b3">3</xref>, Crysalis adopts a two-stage strategy to train the five-class prediction models. In particular, the final features selected via feature selection were used as inputs to initially build SVR models of the first-level predictors, termed Crysalis I. Next, prediction outputs by Crysalis I were used as inputs to build second-level SVR models, termed Crysalis II.</p>
    </sec>
    <sec disp-level="2">
      <title>SVR implementation and parameter optimization</title>
      <p>We used SVR from the LIBSVM package 2.82<xref ref-type="bibr" rid="b40">40</xref> to train and build five-class models for two-level predictors. We used the radial-basis kernel function on the benchmark datasets with default parameters to train SVR models in the process of feature selection and the performance was evaluated via AUC with 5-fold cross-validation. The optimal feature subset for each class was used to build the final model, which was optimized by selecting three available kernels in LIBSVM (sigmoid, radial-basis function, and polynomial) with a grid search of two kernel parameters (<italic>C</italic> and γ). The optimal SVR models for two-level predictors were evaluated on the independent test datasets.</p>
    </sec>
    <sec disp-level="2">
      <title>Design mode</title>
      <p>The design mode is available to improve experimental design of those target proteins that are predicted by Crysalis with a lower propensity score to pass a particular experimental procedure toward successful crystallization, and ultimately, determination of its structure. Hence, the design mode may be regarded as a complementary ‘module’ to the prediction mode, improving the crystallization success rate by focusing on the designed mutants having enhanced propensity rather than the wild-type variant.</p>
      <p>As shown in <xref ref-type="fig" rid="f2">Fig. 2B</xref>, the computational design of Crysalis was implemented based on the analysis of the predicted protein crystallizability propensity by the prediction mode. First, a library of all possible single-point mutations was generated and their sequence information subsequently used as the input to estimate the corresponding crystallizability propensity of each protein mutant. Crysalis then ranks these mutants based on the estimated changes in protein crystallizability following mutation and identifies mutations that may lead to improved crystallizability. These procedures are described in detail below.</p>
    </sec>
    <sec disp-level="2">
      <title>Estimating protein crystallizability changes upon mutation</title>
      <p>The changes in predicted protein crystallizability in response to a given mutation can be computed based on the propensity changes of the predicted experimental procedure (Eq. 2):</p>
      <p>
        <disp-formula id="eq7">
          <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e783" xlink:href="srep21383-m7.jpg"/>
        </disp-formula>
      </p>
      <p>For CRYs prediction, where <inline-formula id="d33e786"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e787" xlink:href="srep21383-m8.jpg"/></inline-formula> is the crystallizability propensity change upon point mutation of protein residue, <italic>i</italic>, from the wild-type (<inline-formula id="d33e792"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e793" xlink:href="srep21383-m9.jpg"/></inline-formula>) to any of the other 19 amino acids, (<inline-formula id="d33e795"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e796" xlink:href="srep21383-m10.jpg"/></inline-formula>, <inline-formula id="d33e798"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e799" xlink:href="srep21383-m11.jpg"/></inline-formula> and <inline-formula id="d33e802"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e803" xlink:href="srep21383-m12.jpg"/></inline-formula> denote the prediction scores of the mutant (<italic>AA</italic><sub>o</sub> mutated to <italic>AA</italic><sub>n</sub> for the residue <italic>i</italic>) and wild-type sequences using the Crysalis II predictor. Finally, Crysalis is able to generate a comprehensive list of designed (or prioritized) mutants ranked and annotated with their corresponding changes in propensity scores.</p>
    </sec>
    <sec disp-level="2">
      <title>Identifying residues (sites) susceptible to protein crystallizability</title>
      <p>In order to identify the key candidate residues amenable to protein engineering capable of improving protein crystallizability, we introduced the score, <inline-formula id="d33e823"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e824" xlink:href="srep21383-m13.jpg"/></inline-formula>, to quantify the degree of non-optimality associated with the amino acid at position <italic>i</italic>, with respect to overall crystallizability:</p>
      <p>
        <disp-formula id="eq14">
          <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e831" xlink:href="srep21383-m14.jpg"/>
        </disp-formula>
      </p>
      <p>where <inline-formula id="d33e834"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e835" xlink:href="srep21383-m15.jpg"/></inline-formula> is the corresponding predicted crystallizability change. The <inline-formula id="d33e837"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e838" xlink:href="srep21383-m16.jpg"/></inline-formula> score is the sum of all mutations predicted to increase protein crystallizability at a given position. If mutations are predicted to decrease the propensity of protein crystallizability, <inline-formula id="d33e840"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e841" xlink:href="srep21383-m17.jpg"/></inline-formula> is expected to be close to zero for those residue positions. This situation implies that the wild-type residue should be maintained, as it is regarded as the optimal selection for protein crystallization. However, if the position <italic>i</italic>, results in positive and large values of <inline-formula id="d33e846"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e847" xlink:href="srep21383-m18.jpg"/></inline-formula>, this indicates that the corresponding residue could be an interesting candidate for mutation, due to the associated increase in protein crystallizability.</p>
    </sec>
    <sec disp-level="2">
      <title>Complementary functional annotations of the target protein</title>
      <p>Point mutations that occur within a functional domain or interrupt functional sites would be unfavorable compared to other mutation options that localize outside functional domain regions. Such functional annotations are expected to facilitate the selection of mutants and hypothesis-driven experimental analysis. Therefore, Crysalis integrates annotations of transmembrane segments, functional domains, and conserved residues of the target protein generated through the following online web servers: (1) TOPCONS-single<xref ref-type="bibr" rid="b41">41</xref> for transmembrane segments, (2) COPRED<xref ref-type="bibr" rid="b42">42</xref> for functional domain assignment, (3) PSIPRED<xref ref-type="bibr" rid="b43">43</xref> for prediction of the secondary-structure elements of the query protein, including α-helices (H), β-strands (E), and coils (C), (4) natively disordered region in the query protein predicted by DISOPRED 2<xref ref-type="bibr" rid="b44">44</xref>, and (5) ACCpro 4.1<xref ref-type="bibr" rid="b45">45</xref> for solvent accessibility prediction in terms of residue exposure or burial status.</p>
    </sec>
    <sec disp-level="2">
      <title>Performance evaluationj</title>
      <p>To evaluate the performance of Crysalis SVR models, we used AUC as the primary measure. In model training and optimization processes, the AUC score is the primary measure for evaluating model performance as suggested by our previous work<xref ref-type="bibr" rid="b3">3</xref>. In addition to the AUC, we also employed several other measures to evaluate performance of the final Crysalis SVR predictors and compare with other methods:</p>
      <p>
        <disp-formula id="eq19">
          <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e873" xlink:href="srep21383-m19.jpg"/>
        </disp-formula>
      </p>
      <p>
        <disp-formula id="eq20">
          <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e876" xlink:href="srep21383-m20.jpg"/>
        </disp-formula>
      </p>
      <p>
        <disp-formula id="eq21">
          <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e879" xlink:href="srep21383-m21.jpg"/>
        </disp-formula>
      </p>
      <p>
        <disp-formula id="eq22">
          <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e882" xlink:href="srep21383-m22.jpg"/>
        </disp-formula>
      </p>
      <p>
        <disp-formula id="eq23">
          <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e885" xlink:href="srep21383-m23.jpg"/>
        </disp-formula>
      </p>
      <p>where <italic>TP</italic>, <italic>FP</italic>, <italic>TN</italic>, and <italic>FN</italic> are the numbers of true positives, false positives, true negatives, and false negatives, respectively. Specifically, <italic>TP</italic> and <italic>TN</italic> denote the numbers of correctly predicted successful and failed trials of a given experimental procedure, respectively, while <italic>FP</italic> and <italic>FN</italic> signify the numbers of incorrectly predicted successful and failed trials of a given experimental procedure, respectively.</p>
    </sec>
  </sec>
  <sec disp-level="1">
    <title>Additional Information</title>
    <p><bold>How to cite this article</bold>: Wang, H. <italic>et al.</italic> Crysalis: an integrated server for computational analysis and design of protein crystallization. <italic>Sci. Rep.</italic>
<bold>6</bold>, 21383; doi: 10.1038/srep21383 (2016).</p>
  </sec>
  <sec sec-type="supplementary-material" id="S1">
    <title>Supplementary Material</title>
    <supplementary-material id="d33e46" content-type="local-data">
      <caption>
        <title>Supplementary Information</title>
      </caption>
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep21383-s1.pdf"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack>
    <p>This work was supported by grants from the National Natural Science Foundation of China (61202167, 61303169, 11250110508, 31350110507), Hundred Talents Program of the Chinese Academy of Sciences (CAS), Knowledge Innovation Program of CAS (KSCX2-EW-G-8), National Health and Medical Research Council of Australia (NHMRC) (490989) and Australian Research Council (ARC) (LP110200333). GIW is a recipient of the ARC Discovery Outstanding Researcher Ward (DORA). JS is a recipient of the Hundred Talents Program of CAS.</p>
  </ack>
  <ref-list>
    <ref id="b1">
      <mixed-citation publication-type="journal"><name><surname>Burley</surname><given-names>S. K.</given-names></name><article-title>An overview of structural genomics</article-title>. <source>Nature Struct. Mol. Biol.</source><volume>7</volume>, <fpage>932</fpage>–<lpage>934</lpage> (<year>2000</year>).</mixed-citation>
    </ref>
    <ref id="b2">
      <mixed-citation publication-type="journal"><name><surname>Mizianty</surname><given-names>M. J.</given-names></name> &amp; <name><surname>Kurgan</surname><given-names>L.</given-names></name>
<article-title>Sequence-based prediction of protein crystallization, purification and production propensity</article-title>. <source>Bioinformatics</source>
<volume>27</volume>, <fpage>i24</fpage>–<lpage>i33</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21685077</pub-id></mixed-citation>
    </ref>
    <ref id="b3">
      <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>H.</given-names></name><italic>et al.</italic><article-title>PredPPCrys: accurate prediction of sequence cloning, protein production, purification and crystallization propensity from protein sequences using multi-step heterogeneous feature fusion and selection</article-title>. <source>PloS one</source><volume>9</volume>, <fpage>e105902</fpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25148528</pub-id></mixed-citation>
    </ref>
    <ref id="b4">
      <mixed-citation publication-type="journal"><name><surname>Smialowski</surname><given-names>P.</given-names></name>, <name><surname>Schmidt</surname><given-names>T.</given-names></name>, <name><surname>Cox</surname><given-names>J.</given-names></name>, <name><surname>Kirschner</surname><given-names>A.</given-names></name> &amp; <name><surname>Frishman</surname><given-names>D.</given-names></name>
<article-title>Will my protein crystallize? A sequence-based predictor</article-title>. <source>Proteins</source>
<volume>62</volume>, <fpage>343</fpage>–<lpage>355</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16315316</pub-id></mixed-citation>
    </ref>
    <ref id="b5">
      <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>K.</given-names></name>, <name><surname>Kurgan</surname><given-names>L.</given-names></name> &amp; <name><surname>Rahbari</surname><given-names>M.</given-names></name>
<article-title>Prediction of protein crystallization using collocation of amino acid pairs</article-title>. <source>Biochem. Bioph. Res. Co.</source>
<volume>355</volume>, <fpage>764</fpage>–<lpage>769</lpage> (<year>2007</year>).</mixed-citation>
    </ref>
    <ref id="b6">
      <mixed-citation publication-type="journal"><name><surname>Overton</surname><given-names>I. M.</given-names></name> &amp; <name><surname>Barton</surname><given-names>G. J.</given-names></name>
<article-title>A normalised scale for structural genomics target ranking: the OB-Score</article-title>. <source>FEBS Lett.</source>
<volume>580</volume>, <fpage>4005</fpage>–<lpage>4009</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16808918</pub-id></mixed-citation>
    </ref>
    <ref id="b7">
      <mixed-citation publication-type="journal"><name><surname>Overton</surname><given-names>I. M.</given-names></name>, <name><surname>Padovani</surname><given-names>G.</given-names></name>, <name><surname>Girolami</surname><given-names>M. A.</given-names></name> &amp; <name><surname>Barton</surname><given-names>G. J.</given-names></name>
<article-title>ParCrys: a Parzen window density estimation approach to protein crystallization propensity prediction</article-title>. <source>Bioinformatics</source>
<volume>24</volume>, <fpage>901</fpage>–<lpage>907</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18285371</pub-id></mixed-citation>
    </ref>
    <ref id="b8">
      <mixed-citation publication-type="journal"><name><surname>Kurgan</surname><given-names>L.</given-names></name><italic>et al.</italic><article-title>CRYSTALP2: sequence-based protein crystallization propensity prediction</article-title>. <source>BMC Struct. Biol</source><volume>9</volume>, <fpage>50</fpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19646256</pub-id></mixed-citation>
    </ref>
    <ref id="b9">
      <mixed-citation publication-type="journal"><name><surname>Babnigg</surname><given-names>G.</given-names></name> &amp; <name><surname>Joachimiak</surname><given-names>A.</given-names></name>
<article-title>Predicting protein crystallization propensity from protein sequence</article-title>. <source>J. Struct.Funct. Genomics</source>
<volume>11</volume>, <fpage>71</fpage>–<lpage>80</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20177794</pub-id></mixed-citation>
    </ref>
    <ref id="b10">
      <mixed-citation publication-type="journal"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name><italic>et al.</italic><article-title>SCMCRYS: predicting protein crystallization using an ensemble scoring card method with estimating propensity scores of P-collocated amino acid pairs</article-title>. <source>PloS One</source><volume>8</volume>, <fpage>e72368</fpage> (<year>2013</year>).<pub-id pub-id-type="pmid">24019868</pub-id></mixed-citation>
    </ref>
    <ref id="b11">
      <mixed-citation publication-type="journal"><name><surname>Slabinski</surname><given-names>L.</given-names></name><italic>et al.</italic><article-title>XtalPred: a web server for prediction of protein crystallizability</article-title>. <source>Bioinformatics</source><volume>23</volume>, <fpage>3403</fpage>–<lpage>3405</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17921170</pub-id></mixed-citation>
    </ref>
    <ref id="b12">
      <mixed-citation publication-type="journal"><name><surname>Price</surname><given-names>Ii, W. N.</given-names></name><italic>et al.</italic><article-title>Understanding the physical properties that control protein crystallization by analysis of large-scale experimental data</article-title>. <source>Nat. Biotechnol.</source><volume>27</volume>, <fpage>51</fpage>–<lpage>57</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19079241</pub-id></mixed-citation>
    </ref>
    <ref id="b13">
      <mixed-citation publication-type="journal"><name><surname>Kandaswamy</surname><given-names>K. K.</given-names></name>, <name><surname>Pugalenthi</surname><given-names>G.</given-names></name>, <name><surname>Suganthan</surname><given-names>P.</given-names></name> &amp; <name><surname>Gangal</surname><given-names>R.</given-names></name>
<article-title>SVMCRYS: an SVM approach for the prediction of protein crystallization propensity from protein sequence</article-title>. <source>Protein Peptide Lett.</source>
<volume>17</volume>, <fpage>423</fpage>–<lpage>430</lpage> (<year>2010</year>).</mixed-citation>
    </ref>
    <ref id="b14">
      <mixed-citation publication-type="journal"><name><surname>Overton</surname><given-names>I. M.</given-names></name>, <name><surname>van Niekerk</surname><given-names>C.</given-names></name> &amp; <name><surname>Barton</surname><given-names>G. J.</given-names></name>
<article-title>XANNpred: Neural nets that predict the propensity of a protein to yield diffraction‐quality crystals</article-title>. <source>Proteins</source>
<volume>79</volume>, <fpage>1027</fpage>–<lpage>1033</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21246630</pub-id></mixed-citation>
    </ref>
    <ref id="b15">
      <mixed-citation publication-type="journal"><name><surname>Jahandideh</surname><given-names>S.</given-names></name> &amp; <name><surname>Mahdavi</surname><given-names>A.</given-names></name>
<article-title>RFCRYS: Sequence-based protein crystallization propensity prediction by means of random forest</article-title>. <source>J Theor. Biol.</source>
<volume>306</volume>, <fpage>115</fpage>–<lpage>119</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22726810</pub-id></mixed-citation>
    </ref>
    <ref id="b16">
      <mixed-citation publication-type="journal"><name><surname>A Kurgan</surname><given-names>L.</given-names></name><article-title>CRYSpred: accurate sequence-based protein crystallization propensity prediction using sequence-derived structural characteristics</article-title>. <source>Protein Peptide Lett.</source><volume>19</volume>, <fpage>40</fpage>–<lpage>49</lpage> (<year>2012</year>).</mixed-citation>
    </ref>
    <ref id="b17">
      <mixed-citation publication-type="journal"><name><surname>Jahandideh</surname><given-names>S.</given-names></name>, <name><surname>Jaroszewski</surname><given-names>L.</given-names></name> &amp; <name><surname>Godzik</surname><given-names>A.</given-names></name>
<article-title>Improving the chances of successful protein structure determination with a random forest classifier</article-title>. <source>Acta Crystallogr. D</source>
<volume>70</volume>, <fpage>627</fpage>–<lpage>635</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24598732</pub-id></mixed-citation>
    </ref>
    <ref id="b18">
      <mixed-citation publication-type="journal"><name><surname>Joachimiak</surname><given-names>A.</given-names></name><article-title>High-throughput crystallography for structural genomics</article-title>. <source>Curr. Opin. Struc. Biol.</source><volume>19</volume>, <fpage>573</fpage>–<lpage>584</lpage> (<year>2009</year>).</mixed-citation>
    </ref>
    <ref id="b19">
      <mixed-citation publication-type="journal"><name><surname>Derewenda</surname><given-names>Z. S.</given-names></name><article-title>The use of recombinant methods and molecular engineering in protein crystallization</article-title>. <source>Methods</source><volume>34</volume>, <fpage>354</fpage>–<lpage>363</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15325653</pub-id></mixed-citation>
    </ref>
    <ref id="b20">
      <mixed-citation publication-type="journal"><name><surname>Ruggiero</surname><given-names>A.</given-names></name>, <name><surname>Smaldone</surname><given-names>G.</given-names></name>, <name><surname>Squeglia</surname><given-names>F.</given-names></name> &amp; <name><surname>Berisio</surname><given-names>R.</given-names></name>
<article-title>Enhanced crystallizability by protein engineering approaches: a general overview</article-title>. <source>Protein Peptide Lett.</source>
<volume>19</volume>, <fpage>732</fpage>–<lpage>742</lpage> (<year>2012</year>).</mixed-citation>
    </ref>
    <ref id="b21">
      <mixed-citation publication-type="journal"><name><surname>Overton</surname><given-names>I. M.</given-names></name> &amp; <name><surname>Barton</surname><given-names>G. J.</given-names></name>
<article-title>Computational approaches to selecting and optimising targets for structural biology</article-title>. <source>Methods</source>
<volume>55</volume>, <fpage>3</fpage>–<lpage>11</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21906678</pub-id></mixed-citation>
    </ref>
    <ref id="b22">
      <mixed-citation publication-type="journal"><name><surname>Cooper</surname><given-names>D. R.</given-names></name><italic>et al.</italic><article-title>Protein crystallization by surface entropy reduction: optimization of the SER strategy</article-title>. <source>Acta Crystallogr. D</source><volume>63</volume>, <fpage>636</fpage>–<lpage>645</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17452789</pub-id></mixed-citation>
    </ref>
    <ref id="b23">
      <mixed-citation publication-type="journal"><name><surname>Goldschmidt</surname><given-names>L.</given-names></name>, <name><surname>Cooper</surname><given-names>D. R.</given-names></name>, <name><surname>Derewenda</surname><given-names>Z. S.</given-names></name> &amp; <name><surname>Eisenberg</surname><given-names>D.</given-names></name>
<article-title>Toward rational protein crystallization: A Web server for the design of crystallizable protein variants</article-title>. <source>Protein Sci.</source>
<volume>16</volume>, <fpage>1569</fpage>–<lpage>1576</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17656576</pub-id></mixed-citation>
    </ref>
    <ref id="b24">
      <mixed-citation publication-type="journal"><name><surname>Kawashima</surname><given-names>S.</given-names></name><italic>et al.</italic><article-title>AAindex: amino acid index database, progress report 2008</article-title>. <source>Nucleic Acids Res.</source><volume>36</volume>, <fpage>D202</fpage>–<lpage>D205</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">17998252</pub-id></mixed-citation>
    </ref>
    <ref id="b25">
      <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>M.</given-names></name><italic>et al.</italic><article-title>Cascleave 2.0, a new approach for predicting caspase and granzyme cleavage targets</article-title>. <source>Bioinformatics</source><volume>30</volume>, <fpage>71</fpage>–<lpage>80</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24149049</pub-id></mixed-citation>
    </ref>
    <ref id="b26">
      <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Y.</given-names></name><italic>et al.</italic><article-title>Accurate <italic>in silico</italic> identification of species-specific acetylation sites by integrating protein sequence-derived and functional features</article-title>. <source>Sci. Rep.</source><volume>4</volume>, <fpage>5765</fpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25042424</pub-id></mixed-citation>
    </ref>
    <ref id="b27">
      <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>K.</given-names></name>, <name><surname>Kurgan</surname><given-names>L. A.</given-names></name> &amp; <name><surname>Ruan</surname><given-names>J.</given-names></name>
<article-title>Prediction of flexible/rigid regions from protein sequences using k-spaced amino acid pairs</article-title>. <source>BMC Struct. Biol.</source>
<volume>7</volume>, <fpage>25</fpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17437643</pub-id></mixed-citation>
    </ref>
    <ref id="b28">
      <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>Y.-Z.</given-names></name>, <name><surname>Tang</surname><given-names>Y.-R.</given-names></name>, <name><surname>Sheng</surname><given-names>Z.-Y.</given-names></name> &amp; <name><surname>Zhang</surname><given-names>Z.</given-names></name>
<article-title>Prediction of mucin-type O-glycosylation sites in mammalian proteins using the composition of k-spaced amino acid pairs</article-title>. <source>BMC Bioinformatics</source>
<volume>9</volume>, <fpage>101</fpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18282281</pub-id></mixed-citation>
    </ref>
    <ref id="b29">
      <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>Z.</given-names></name><italic>et al.</italic><article-title>Prediction of ubiquitination sites by using the composition of k-spaced amino acid pairs</article-title>. <source>PloS One</source><volume>6</volume>, <fpage>e22930</fpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21829559</pub-id></mixed-citation>
    </ref>
    <ref id="b30">
      <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>Z.</given-names></name>, <name><surname>Zhou</surname><given-names>Y.</given-names></name>, <name><surname>Song</surname><given-names>J.</given-names></name> &amp; <name><surname>Zhang</surname><given-names>Z.</given-names></name>
<article-title>hCKSAAP_UbSite: Improved prediction of human ubiquitination sites by exploiting amino acid pattern and properties</article-title>. <source>BBA-Proteins Proteom.</source>
<volume>1834</volume>, <fpage>1461</fpage>–<lpage>1467</lpage> (<year>2013</year>).</mixed-citation>
    </ref>
    <ref id="b31">
      <mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>X.</given-names></name>, <name><surname>Zhang</surname><given-names>W.</given-names></name>, <name><surname>Xu</surname><given-names>X.</given-names></name>, <name><surname>Ma</surname><given-names>Z.</given-names></name> &amp; <name><surname>Yin</surname><given-names>M.</given-names></name>
<article-title>Prediction of protein phosphorylation sites by using the composition of k-spaced amino acid pairs</article-title>. <source>PloS One</source>
<volume>10</volume>, <fpage>e46302</fpage> (<year>2012</year>).<pub-id pub-id-type="pmid">23110047</pub-id></mixed-citation>
    </ref>
    <ref id="b32">
      <mixed-citation publication-type="journal"><name><surname>Rao</surname><given-names>H.</given-names></name>, <name><surname>Zhu</surname><given-names>F.</given-names></name>, <name><surname>Yang</surname><given-names>G.</given-names></name>, <name><surname>Li</surname><given-names>Z.</given-names></name> &amp; <name><surname>Chen</surname><given-names>Y.</given-names></name>
<article-title>Update of PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence</article-title>. <source>Nucleic Acids Res.</source>
<volume>39</volume>, <fpage>W385</fpage>–<lpage>W390</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21609959</pub-id></mixed-citation>
    </ref>
    <ref id="b33">
      <mixed-citation publication-type="journal"><name><surname>Dehouck</surname><given-names>Y.</given-names></name>, <name><surname>Kwasigroch</surname><given-names>J. M.</given-names></name>, <name><surname>Gilis</surname><given-names>D.</given-names></name> &amp; <name><surname>Rooman</surname><given-names>M.</given-names></name>
<article-title>PoPMuSiC 2.1: a web server for the estimation of protein stability changes upon mutation and sequence optimality</article-title>. <source>BMC bioinformatics</source>
<volume>12</volume>, <fpage>151</fpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21569468</pub-id></mixed-citation>
    </ref>
    <ref id="b34">
      <mixed-citation publication-type="journal"><name><surname>Pruitt</surname><given-names>K. D.</given-names></name>, <name><surname>Tatusova</surname><given-names>T.</given-names></name>, <name><surname>Brown</surname><given-names>G. R.</given-names></name> &amp; <name><surname>Maglott</surname><given-names>D. R.</given-names></name>
<article-title>NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy</article-title>. <source>Nucleic Acids Res.</source>
<volume>40</volume>, <fpage>D130</fpage>–<lpage>D135</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22121212</pub-id></mixed-citation>
    </ref>
    <ref id="b35">
      <mixed-citation publication-type="journal"><name><surname>Hoover</surname><given-names>D. M.</given-names></name> &amp; <name><surname>Lubkowski</surname><given-names>J.</given-names></name>
<article-title>DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis</article-title>. <source>Nucleic Acids Res.</source>
<volume>30</volume>, <fpage>e43</fpage>–<lpage>e43</lpage> (<year>2002</year>).<pub-id pub-id-type="pmid">12000848</pub-id></mixed-citation>
    </ref>
    <ref id="b36">
      <mixed-citation publication-type="journal"><name><surname>Brown</surname><given-names>T.</given-names></name><source>(2010) Gene cloning and DNA analysis: an introduction</source> (John Wiley &amp; Sons, <year>2010</year>).</mixed-citation>
    </ref>
    <ref id="b37">
      <mixed-citation publication-type="journal"><name><surname>Tian</surname><given-names>J.</given-names></name><italic>et al.</italic><article-title>Accurate multiplex gene synthesis from programmable DNA microchips</article-title>. <source>Nature</source><volume>432</volume>, <fpage>1050</fpage>–<lpage>1054</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15616567</pub-id></mixed-citation>
    </ref>
    <ref id="b38">
      <mixed-citation publication-type="journal"><name><surname>Kouranov</surname><given-names>A.</given-names></name><italic>et al.</italic><article-title>The RCSB PDB information portal for structural genomics</article-title>. <source>Nucleic Acids Res.</source><volume>34</volume>, <fpage>D302</fpage>–<lpage>D305</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16381872</pub-id></mixed-citation>
    </ref>
    <ref id="b39">
      <mixed-citation publication-type="journal"><name><surname>Ding</surname><given-names>C.</given-names></name> &amp; <name><surname>Peng</surname><given-names>H.</given-names></name>
<article-title>Minimum redundancy feature selection from microarray gene expression data</article-title>. <source>J. Bioinfor. Comput. Biol.</source>
<volume>3</volume>, <fpage>185</fpage>–<lpage>205</lpage> (<year>2005</year>).</mixed-citation>
    </ref>
    <ref id="b40">
      <mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>C.-C.</given-names></name> &amp; <name><surname>Lin</surname><given-names>C.-J.</given-names></name>
<article-title>LIBSVM: A library for support vector machines</article-title>. <source>ACM T. Intel. Syst. Tec.</source>
<volume>2</volume>, <fpage>27</fpage> (<year>2011</year>).</mixed-citation>
    </ref>
    <ref id="b41">
      <mixed-citation publication-type="journal"><name><surname>Hennerdal</surname><given-names>A.</given-names></name> &amp; <name><surname>Elofsson</surname><given-names>A.</given-names></name>
<article-title>Rapid membrane protein topology prediction</article-title>. <source>Bioinformatics</source>
<volume>27</volume>, <fpage>1322</fpage>–<lpage>1323</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21493661</pub-id></mixed-citation>
    </ref>
    <ref id="b42">
      <mixed-citation publication-type="journal"><name><surname>López</surname><given-names>D.</given-names></name> &amp; <name><surname>Pazos</surname><given-names>F.</given-names></name>
<article-title>COPRED: prediction of fold, GO molecular function and functional residues at the domain level</article-title>. <source>Bioinformatics</source>
<volume>29</volume>, <fpage>1811</fpage>–<lpage>1812</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23720488</pub-id></mixed-citation>
    </ref>
    <ref id="b43">
      <mixed-citation publication-type="journal"><name><surname>Buchan</surname><given-names>D. W.</given-names></name>, <name><surname>Minneci</surname><given-names>F.</given-names></name>, <name><surname>Nugent</surname><given-names>T. C.</given-names></name>, <name><surname>Bryson</surname><given-names>K.</given-names></name> &amp; <name><surname>Jones</surname><given-names>D. T.</given-names></name>
<article-title>Scalable web services for the PSIPRED Protein Analysis Workbench</article-title>. <source>Nucleic Acids Res.</source>
<volume>41</volume>, <fpage>W349</fpage>–<lpage>W357</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23748958</pub-id></mixed-citation>
    </ref>
    <ref id="b44">
      <mixed-citation publication-type="journal"><name><surname>Ward</surname><given-names>J. J.</given-names></name>, <name><surname>McGuffin</surname><given-names>L. J.</given-names></name>, <name><surname>Bryson</surname><given-names>K.</given-names></name>, <name><surname>Buxton</surname><given-names>B. F.</given-names></name> &amp; <name><surname>Jones</surname><given-names>D. T.</given-names></name>
<article-title>The DISOPRED server for the prediction of protein disorder</article-title>. <source>Bioinformatics</source>
<volume>20</volume>, <fpage>2138</fpage>–<lpage>2139</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15044227</pub-id></mixed-citation>
    </ref>
    <ref id="b45">
      <mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>J.</given-names></name>, <name><surname>Randall</surname><given-names>A. Z.</given-names></name>, <name><surname>Sweredoski</surname><given-names>M. J.</given-names></name> &amp; <name><surname>Baldi</surname><given-names>P.</given-names></name>
<article-title>SCRATCH: a protein structure and structural feature prediction server</article-title>. <source>Nucleic Acids Res.</source>
<volume>33</volume>, <fpage>W72</fpage>–<lpage>W76</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15980571</pub-id></mixed-citation>
    </ref>
  </ref-list>
  <fn-group>
    <fn>
      <p><bold>Author Contributions</bold> H.W. collected the data, performed the experiments, wrote the programs and analyzed the data. L.F., Z.Z., G.I.W. and D.L. analyzed the data and contributed to the writing of the programs. H.W. and J.S. designed the algorithm and analyzed the data. H.W. and J.S. wrote the manuscript. All authors discussed and commented on the manuscript.</p>
    </fn>
  </fn-group>
</back>
<floats-group>
  <fig id="f1">
    <label>Figure 1</label>
    <caption>
      <title>AUC-based performance following removal or inclusion of individual four-feature types in the optimal feature set.</title>
      <p>The graphs illustrate the impact on prediction performance of the Crysalis first-level models for all five prediction classes. (<bold>A</bold>) Performance of the trained models following removal of the corresponding feature type. (<bold>B</bold>) Performance of the trained models using the individual feature type. All predicted models are compared with the best models that were trained using the optimal feature sets.</p>
    </caption>
    <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep21383-f1"/>
  </fig>
  <fig id="f2">
    <label>Figure 2</label>
    <caption>
      <p>Schematic illustration of the Crysalis prediction mode (<bold>A</bold>) and design mode (<bold>B</bold>).</p>
    </caption>
    <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep21383-f2"/>
  </fig>
  <table-wrap position="float" id="t1">
    <label>Table 1</label>
    <caption>
      <title>Statistics of the final selected features after one-step and two-step feature selection for each class of experimental procedure.</title>
    </caption>
    <table frame="hsides" rules="groups" border="1">
      <colgroup>
        <col align="left"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
      </colgroup>
      <thead valign="bottom">
        <tr>
          <th rowspan="2" align="left" valign="top" charoff="50">Feature type</th>
          <th colspan="2" align="center" valign="top" charoff="50">CLF<hr/></th>
          <th colspan="2" align="center" valign="top" charoff="50">MF<hr/></th>
          <th colspan="2" align="center" valign="top" charoff="50">PF<hr/></th>
          <th colspan="2" align="center" valign="top" charoff="50">CF<hr/></th>
          <th colspan="2" align="center" valign="top" charoff="50">CRYs<hr/></th>
        </tr>
        <tr>
          <th align="center" valign="top" charoff="50">OFS</th>
          <th align="center" valign="top" charoff="50">TFS</th>
          <th align="center" valign="top" charoff="50">OFS</th>
          <th align="center" valign="top" charoff="50">TFS</th>
          <th align="center" valign="top" charoff="50">OFS</th>
          <th align="center" valign="top" charoff="50">TFS</th>
          <th align="center" valign="top" charoff="50">OFS</th>
          <th align="center" valign="top" charoff="50">TFS</th>
          <th align="center" valign="top" charoff="50">OFS</th>
          <th align="center" valign="top" charoff="50">TFS</th>
        </tr>
      </thead>
      <tbody valign="top">
        <tr>
          <td align="left" valign="top" charoff="50">AAc</td>
          <td align="center" valign="top" charoff="50">1</td>
          <td align="center" valign="top" charoff="50">0</td>
          <td align="center" valign="top" charoff="50">3</td>
          <td align="center" valign="top" charoff="50">3</td>
          <td align="center" valign="top" charoff="50">1</td>
          <td align="center" valign="top" charoff="50">1</td>
          <td align="center" valign="top" charoff="50">1</td>
          <td align="center" valign="top" charoff="50">1</td>
          <td align="center" valign="top" charoff="50">1</td>
          <td align="center" valign="top" charoff="50">1</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">Tri-peptide</td>
          <td align="center" valign="top" charoff="50">2</td>
          <td align="center" valign="top" charoff="50">2</td>
          <td align="center" valign="top" charoff="50">6</td>
          <td align="center" valign="top" charoff="50">4</td>
          <td align="center" valign="top" charoff="50">10</td>
          <td align="center" valign="top" charoff="50">9</td>
          <td align="center" valign="top" charoff="50">3</td>
          <td align="center" valign="top" charoff="50">1</td>
          <td align="center" valign="top" charoff="50">9</td>
          <td align="center" valign="top" charoff="50">6</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">AAindex</td>
          <td align="center" valign="top" charoff="50">7</td>
          <td align="center" valign="top" charoff="50">1</td>
          <td align="center" valign="top" charoff="50">22</td>
          <td align="center" valign="top" charoff="50">20</td>
          <td align="center" valign="top" charoff="50">10</td>
          <td align="center" valign="top" charoff="50">8</td>
          <td align="center" valign="top" charoff="50">1</td>
          <td align="center" valign="top" charoff="50">1</td>
          <td align="center" valign="top" charoff="50">24</td>
          <td align="center" valign="top" charoff="50">21</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">KSAAP</td>
          <td align="center" valign="top" charoff="50">86</td>
          <td align="center" valign="top" charoff="50">21</td>
          <td align="center" valign="top" charoff="50">19</td>
          <td align="center" valign="top" charoff="50">13</td>
          <td align="center" valign="top" charoff="50">66</td>
          <td align="center" valign="top" charoff="50">64</td>
          <td align="center" valign="top" charoff="50">94</td>
          <td align="center" valign="top" charoff="50">65</td>
          <td align="center" valign="top" charoff="50">26</td>
          <td align="center" valign="top" charoff="50">13</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">GKSAAP</td>
          <td align="center" valign="top" charoff="50">4</td>
          <td align="center" valign="top" charoff="50">0</td>
          <td align="center" valign="top" charoff="50">50</td>
          <td align="center" valign="top" charoff="50">38</td>
          <td align="center" valign="top" charoff="50">13</td>
          <td align="center" valign="top" charoff="50">13</td>
          <td align="center" valign="top" charoff="50">1</td>
          <td align="center" valign="top" charoff="50">0</td>
          <td align="center" valign="top" charoff="50">40</td>
          <td align="center" valign="top" charoff="50">24</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">Total</td>
          <td align="center" valign="top" charoff="50">100</td>
          <td align="center" valign="top" charoff="50">24</td>
          <td align="center" valign="top" charoff="50">100</td>
          <td align="center" valign="top" charoff="50">78</td>
          <td align="center" valign="top" charoff="50">100</td>
          <td align="center" valign="top" charoff="50">95</td>
          <td align="center" valign="top" charoff="50">100</td>
          <td align="center" valign="top" charoff="50">68</td>
          <td align="center" valign="top" charoff="50">100</td>
          <td align="center" valign="top" charoff="50">65</td>
        </tr>
      </tbody>
    </table>
    <table-wrap-foot>
      <fn id="t1-fn1">
        <p>Feature selection was performed on the benchmark datasets.</p>
      </fn>
      <fn id="t1-fn2">
        <p>OFS (One-method Feature Selection) denotes results after two-step feature selection (mRMR).</p>
      </fn>
      <fn id="t1-fn3">
        <p>TFS (Two-method Feature Selection) denotes results after three-step feature selection (mRMR+FFS).</p>
      </fn>
      <fn id="t1-fn4">
        <p>AAc: features generated based on 20 standard amino acids.</p>
      </fn>
    </table-wrap-foot>
  </table-wrap>
  <table-wrap position="float" id="t2">
    <label>Table 2</label>
    <caption>
      <title>Performance comparison of first-level SVR predictors from PredPPCrys and Crysalis.</title>
    </caption>
    <table frame="hsides" rules="groups" border="1">
      <colgroup>
        <col align="left"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
      </colgroup>
      <thead valign="bottom">
        <tr>
          <th align="left" valign="top" charoff="50"> </th>
          <th align="center" valign="top" charoff="50">Models</th>
          <th align="center" valign="top" charoff="50">Features<xref ref-type="fn" rid="t2-fn1">#</xref></th>
          <th align="center" valign="top" charoff="50">AUC</th>
          <th align="center" valign="top" charoff="50">MCC</th>
          <th align="center" valign="top" charoff="50">ACC(%)</th>
          <th align="center" valign="top" charoff="50">SPE(%)</th>
          <th align="center" valign="top" charoff="50">SEN(%)</th>
          <th align="center" valign="top" charoff="50">PRE(%)</th>
        </tr>
      </thead>
      <tbody valign="top">
        <tr>
          <td rowspan="2" align="left" valign="middle" charoff="50">CLF</td>
          <td align="center" valign="top" charoff="50">PredPPCrys</td>
          <td align="center" valign="top" charoff="50">31</td>
          <td align="center" valign="top" charoff="50">0.727</td>
          <td align="center" valign="top" charoff="50">0.339</td>
          <td align="center" valign="top" charoff="50">67.8</td>
          <td align="center" valign="top" charoff="50">62.7</td>
          <td align="center" valign="top" charoff="50">71.4</td>
          <td align="center" valign="top" charoff="50">73.3</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis</td>
          <td align="center" valign="top" charoff="50">25</td>
          <td align="center" valign="top" charoff="50">0.732</td>
          <td align="center" valign="top" charoff="50">0.334</td>
          <td align="center" valign="top" charoff="50">66.7</td>
          <td align="center" valign="top" charoff="50">68.6</td>
          <td align="center" valign="top" charoff="50">65.5</td>
          <td align="center" valign="top" charoff="50">76.2</td>
        </tr>
        <tr>
          <td rowspan="2" align="left" valign="middle" charoff="50">MF</td>
          <td align="center" valign="top" charoff="50">PredPPCrys</td>
          <td align="center" valign="top" charoff="50">43</td>
          <td align="center" valign="top" charoff="50">0.777</td>
          <td align="center" valign="top" charoff="50">0.384</td>
          <td align="center" valign="top" charoff="50">70.3</td>
          <td align="center" valign="top" charoff="50">69.6</td>
          <td align="center" valign="top" charoff="50">71.8</td>
          <td align="center" valign="top" charoff="50">50.4</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis</td>
          <td align="center" valign="top" charoff="50">78</td>
          <td align="center" valign="top" charoff="50">0.767</td>
          <td align="center" valign="top" charoff="50">0.400</td>
          <td align="center" valign="top" charoff="50">70.4</td>
          <td align="center" valign="top" charoff="50">68.4</td>
          <td align="center" valign="top" charoff="50">75.1</td>
          <td align="center" valign="top" charoff="50">49.8</td>
        </tr>
        <tr>
          <td rowspan="2" align="left" valign="middle" charoff="50">PF</td>
          <td align="center" valign="top" charoff="50">PredPPCrys</td>
          <td align="center" valign="top" charoff="50">54</td>
          <td align="center" valign="top" charoff="50">0.790</td>
          <td align="center" valign="top" charoff="50">0.445</td>
          <td align="center" valign="top" charoff="50">73.8</td>
          <td align="center" valign="top" charoff="50">70.5</td>
          <td align="center" valign="top" charoff="50">75.5</td>
          <td align="center" valign="top" charoff="50">83.3</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis</td>
          <td align="center" valign="top" charoff="50">95</td>
          <td align="center" valign="top" charoff="50">0.790</td>
          <td align="center" valign="top" charoff="50">0.447</td>
          <td align="center" valign="top" charoff="50">74.4</td>
          <td align="center" valign="top" charoff="50">69.0</td>
          <td align="center" valign="top" charoff="50">77.1</td>
          <td align="center" valign="top" charoff="50">83.4</td>
        </tr>
        <tr>
          <td rowspan="2" align="left" valign="middle" charoff="50">CF</td>
          <td align="center" valign="top" charoff="50">PredPPCrys</td>
          <td align="center" valign="top" charoff="50">229</td>
          <td align="center" valign="top" charoff="50">0.707</td>
          <td align="center" valign="top" charoff="50">0.289</td>
          <td align="center" valign="top" charoff="50">62.7</td>
          <td align="center" valign="top" charoff="50">74.8</td>
          <td align="center" valign="top" charoff="50">58.8</td>
          <td align="center" valign="top" charoff="50">87.8</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis</td>
          <td align="center" valign="top" charoff="50">68</td>
          <td align="center" valign="top" charoff="50">0.737</td>
          <td align="center" valign="top" charoff="50">0.329</td>
          <td align="center" valign="top" charoff="50">70.7</td>
          <td align="center" valign="top" charoff="50">73.3</td>
          <td align="center" valign="top" charoff="50">63.1</td>
          <td align="center" valign="top" charoff="50">85.5</td>
        </tr>
        <tr>
          <td rowspan="2" align="left" valign="middle" charoff="50">CRYs</td>
          <td align="center" valign="top" charoff="50">PredPPCrys</td>
          <td align="center" valign="top" charoff="50">37</td>
          <td align="center" valign="top" charoff="50">0.765</td>
          <td align="center" valign="top" charoff="50">0.309</td>
          <td align="center" valign="top" charoff="50">69.2</td>
          <td align="center" valign="top" charoff="50">69.1</td>
          <td align="center" valign="top" charoff="50">69.3</td>
          <td align="center" valign="top" charoff="50">34.2</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis</td>
          <td align="center" valign="top" charoff="50">65</td>
          <td align="center" valign="top" charoff="50">0.773</td>
          <td align="center" valign="top" charoff="50">0.326</td>
          <td align="center" valign="top" charoff="50">69.2</td>
          <td align="center" valign="top" charoff="50">68.5</td>
          <td align="center" valign="top" charoff="50">72.2</td>
          <td align="center" valign="top" charoff="50">34.7</td>
        </tr>
      </tbody>
    </table>
    <table-wrap-foot>
      <fn id="t2-fn1">
        <p>Performance of all models were evaluated using the benchmark datasets.</p>
      </fn>
      <fn id="t2-fn2">
        <p><sup>#</sup>The number of final selected features used for training the first-level SVR predictors.</p>
      </fn>
    </table-wrap-foot>
  </table-wrap>
  <table-wrap position="float" id="t3">
    <label>Table 3</label>
    <caption>
      <title>Prediction performance comparison of Crysalis and other existing methods.</title>
    </caption>
    <table frame="hsides" rules="groups" border="1">
      <colgroup>
        <col align="left"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
      </colgroup>
      <thead valign="bottom">
        <tr>
          <th align="left" valign="top" charoff="50">Experimental step</th>
          <th align="center" valign="top" charoff="50">Method</th>
          <th align="center" valign="top" charoff="50">AUC</th>
          <th align="center" valign="top" charoff="50">MCC</th>
          <th align="center" valign="top" charoff="50">ACC(%)</th>
          <th align="center" valign="top" charoff="50">SPEC(%)</th>
          <th align="center" valign="top" charoff="50">SENS(%)</th>
          <th align="center" valign="top" charoff="50">PRE(%)</th>
        </tr>
      </thead>
      <tbody valign="top">
        <tr>
          <td rowspan="4" align="left" valign="middle" charoff="50">CLF</td>
          <td align="center" valign="top" charoff="50">PredPPCrys I</td>
          <td align="center" valign="top" charoff="50">0.711</td>
          <td align="center" valign="top" charoff="50">0.296</td>
          <td align="center" valign="top" charoff="50">65.33</td>
          <td align="center" valign="top" charoff="50">63.58</td>
          <td align="center" valign="top" charoff="50">66.50</td>
          <td align="center" valign="top" charoff="50">73.16</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">PredPPCrys II</td>
          <td align="center" valign="top" charoff="50">0.725</td>
          <td align="center" valign="top" charoff="50">0.322</td>
          <td align="center" valign="top" charoff="50">66.54</td>
          <td align="center" valign="top" charoff="50">65.56</td>
          <td align="center" valign="top" charoff="50">67.20</td>
          <td align="center" valign="top" charoff="50">74.44</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis I</td>
          <td align="center" valign="top" charoff="50">0.731</td>
          <td align="center" valign="top" charoff="50">0.332</td>
          <td align="center" valign="top" charoff="50">66.98</td>
          <td align="center" valign="top" charoff="50">66.60</td>
          <td align="center" valign="top" charoff="50">67.22</td>
          <td align="center" valign="top" charoff="50">75.56</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis II</td>
          <td align="center" valign="top" charoff="50">
            <bold>0.759</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>0.365</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>68.34</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>69.95</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>68.34</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>76.85</bold>
          </td>
        </tr>
        <tr>
          <td rowspan="5" align="left" valign="middle" charoff="50">MF</td>
          <td align="center" valign="top" charoff="50">PPCPred</td>
          <td align="center" valign="top" charoff="50">0.683</td>
          <td align="center" valign="top" charoff="50">0.334</td>
          <td align="center" valign="top" charoff="50">68.06</td>
          <td align="center" valign="top" charoff="50">67.99</td>
          <td align="center" valign="top" charoff="50">68.22</td>
          <td align="center" valign="top" charoff="50">47.20</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">PredPPCrys I</td>
          <td align="center" valign="top" charoff="50">0.772</td>
          <td align="center" valign="top" charoff="50">0.380</td>
          <td align="center" valign="top" charoff="50">69.93</td>
          <td align="center" valign="top" charoff="50">68.21</td>
          <td align="center" valign="top" charoff="50">72.88</td>
          <td align="center" valign="top" charoff="50">49.95</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">PredPPCrys II</td>
          <td align="center" valign="top" charoff="50">
            <bold>0.793</bold>
          </td>
          <td align="center" valign="top" charoff="50">0.416</td>
          <td align="center" valign="top" charoff="50">71.95</td>
          <td align="center" valign="top" charoff="50">71.36</td>
          <td align="center" valign="top" charoff="50">73.30</td>
          <td align="center" valign="top" charoff="50">52.70</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis I</td>
          <td align="center" valign="top" charoff="50">0.759</td>
          <td align="center" valign="top" charoff="50">0.377</td>
          <td align="center" valign="top" charoff="50">70.23</td>
          <td align="center" valign="top" charoff="50">69.93</td>
          <td align="center" valign="top" charoff="50">70.99</td>
          <td align="center" valign="top" charoff="50">49.25</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis II</td>
          <td align="center" valign="top" charoff="50">
            <bold>0.793</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>0.427</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>73.08</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>73.58</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>73.09</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>54.15</bold>
          </td>
        </tr>
        <tr>
          <td rowspan="5" align="left" valign="middle" charoff="50">PF</td>
          <td align="center" valign="top" charoff="50">PPCPred</td>
          <td align="center" valign="top" charoff="50">0.612</td>
          <td align="center" valign="top" charoff="50">0.183</td>
          <td align="center" valign="top" charoff="50">58.83</td>
          <td align="center" valign="top" charoff="50">62.23</td>
          <td align="center" valign="top" charoff="50">57.08</td>
          <td align="center" valign="top" charoff="50">74.57</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">PredPPCrys I</td>
          <td align="center" valign="top" charoff="50">0.800</td>
          <td align="center" valign="top" charoff="50">0.460</td>
          <td align="center" valign="top" charoff="50">74.83</td>
          <td align="center" valign="top" charoff="50">70.52</td>
          <td align="center" valign="top" charoff="50">77.02</td>
          <td align="center" valign="top" charoff="50">83.77</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">PredPPCrys II</td>
          <td align="center" valign="top" charoff="50">
            <bold>0.872</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>0.579</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>79.73</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>81.43</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>78.86</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>89.31</bold>
          </td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis I</td>
          <td align="center" valign="top" charoff="50">0.796</td>
          <td align="center" valign="top" charoff="50">0.436</td>
          <td align="center" valign="top" charoff="50">73.87</td>
          <td align="center" valign="top" charoff="50">67.80</td>
          <td align="center" valign="top" charoff="50">73.87</td>
          <td align="center" valign="top" charoff="50">82.47</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis II</td>
          <td align="center" valign="top" charoff="50">0.801</td>
          <td align="center" valign="top" charoff="50">0.411</td>
          <td align="center" valign="top" charoff="50">71.22</td>
          <td align="center" valign="top" charoff="50">72.67</td>
          <td align="center" valign="top" charoff="50">70.48</td>
          <td align="center" valign="top" charoff="50">83.48</td>
        </tr>
        <tr>
          <td rowspan="5" align="left" valign="middle" charoff="50">CF</td>
          <td align="center" valign="top" charoff="50">PPCPred</td>
          <td align="center" valign="top" charoff="50">0.432</td>
          <td align="center" valign="top" charoff="50">−0.014</td>
          <td align="center" valign="top" charoff="50">55.23</td>
          <td align="center" valign="top" charoff="50">32.21</td>
          <td align="center" valign="top" charoff="50">61.24</td>
          <td align="center" valign="top" charoff="50">75.53</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">PredPPCrys I</td>
          <td align="center" valign="top" charoff="50">0.712</td>
          <td align="center" valign="top" charoff="50">0.280</td>
          <td align="center" valign="top" charoff="50">67.05</td>
          <td align="center" valign="top" charoff="50">67.65</td>
          <td align="center" valign="top" charoff="50">66.91</td>
          <td align="center" valign="top" charoff="50">89.42</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">PredPPCrys II</td>
          <td align="center" valign="top" charoff="50">0.735</td>
          <td align="center" valign="top" charoff="50">0.175</td>
          <td align="center" valign="top" charoff="50">
            <bold>69.47</bold>
          </td>
          <td align="center" valign="top" charoff="50">68.89</td>
          <td align="center" valign="top" charoff="50">
            <bold>69.50</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>97.80</bold>
          </td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis I</td>
          <td align="center" valign="top" charoff="50">0.739</td>
          <td align="center" valign="top" charoff="50">0.281</td>
          <td align="center" valign="top" charoff="50">65.50</td>
          <td align="center" valign="top" charoff="50">70.59</td>
          <td align="center" valign="top" charoff="50">64.23</td>
          <td align="center" valign="top" charoff="50">89.80</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis II</td>
          <td align="center" valign="top" charoff="50">
            <bold>0.752</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>0.337</bold>
          </td>
          <td align="center" valign="top" charoff="50">62.57</td>
          <td align="center" valign="top" charoff="50">
            <bold>85.29</bold>
          </td>
          <td align="center" valign="top" charoff="50">56.93</td>
          <td align="center" valign="top" charoff="50">93.97</td>
        </tr>
        <tr>
          <td rowspan="11" align="left" valign="middle" charoff="50">CRYs</td>
          <td align="center" valign="top" charoff="50">ParCrys</td>
          <td align="center" valign="top" charoff="50">0.611</td>
          <td align="center" valign="top" charoff="50">0.132</td>
          <td align="center" valign="top" charoff="50">59.66</td>
          <td align="center" valign="top" charoff="50">60.56</td>
          <td align="center" valign="top" charoff="50">55.91</td>
          <td align="center" valign="top" charoff="50">25.40</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">OBScore</td>
          <td align="center" valign="top" charoff="50">0.638</td>
          <td align="center" valign="top" charoff="50">0.184</td>
          <td align="center" valign="top" charoff="50">59.28</td>
          <td align="center" valign="top" charoff="50">57.78</td>
          <td align="center" valign="top" charoff="50">65.49</td>
          <td align="center" valign="top" charoff="50">27.14</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">CRYSTAP2</td>
          <td align="center" valign="top" charoff="50">0.599</td>
          <td align="center" valign="top" charoff="50">0.123</td>
          <td align="center" valign="top" charoff="50">51.64</td>
          <td align="center" valign="top" charoff="50">48.10</td>
          <td align="center" valign="top" charoff="50">67.78</td>
          <td align="center" valign="top" charoff="50">22.28</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">XtalPred</td>
          <td align="center" valign="top" charoff="50">—</td>
          <td align="center" valign="top" charoff="50">0.224</td>
          <td align="center" valign="top" charoff="50">65.04</td>
          <td align="center" valign="top" charoff="50">65.61</td>
          <td align="center" valign="top" charoff="50">62.51</td>
          <td align="center" valign="top" charoff="50">29.31</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">SVMCRYs</td>
          <td align="center" valign="top" charoff="50">—</td>
          <td align="center" valign="top" charoff="50">0.142</td>
          <td align="center" valign="top" charoff="50">55.11</td>
          <td align="center" valign="top" charoff="50">52.78</td>
          <td align="center" valign="top" charoff="50">65.70</td>
          <td align="center" valign="top" charoff="50">23.39</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">PPCPred</td>
          <td align="center" valign="top" charoff="50">0.704</td>
          <td align="center" valign="top" charoff="50">0.254</td>
          <td align="center" valign="top" charoff="50">63.63</td>
          <td align="center" valign="top" charoff="50">62.09</td>
          <td align="center" valign="top" charoff="50">70.67</td>
          <td align="center" valign="top" charoff="50">29.03</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">XtalPred-RF</td>
          <td align="center" valign="top" charoff="50">—</td>
          <td align="center" valign="top" charoff="50">0.205</td>
          <td align="center" valign="top" charoff="50">60.94</td>
          <td align="center" valign="top" charoff="50">59.67</td>
          <td align="center" valign="top" charoff="50">66.41</td>
          <td align="center" valign="top" charoff="50">27.56</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">PredPPCrys I</td>
          <td align="center" valign="top" charoff="50">0.770</td>
          <td align="center" valign="top" charoff="50">0.326</td>
          <td align="center" valign="top" charoff="50">69.65</td>
          <td align="center" valign="top" charoff="50">69.30</td>
          <td align="center" valign="top" charoff="50">71.13</td>
          <td align="center" valign="top" charoff="50">35.23</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">PredPPCrys II</td>
          <td align="center" valign="top" charoff="50">
            <bold>0.838</bold>
          </td>
          <td align="center" valign="top" charoff="50">0.428</td>
          <td align="center" valign="top" charoff="50">76.04</td>
          <td align="center" valign="top" charoff="50">76.21</td>
          <td align="center" valign="top" charoff="50">75.30</td>
          <td align="center" valign="top" charoff="50">42.64</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis I</td>
          <td align="center" valign="top" charoff="50">0.788</td>
          <td align="center" valign="top" charoff="50">0.339</td>
          <td align="center" valign="top" charoff="50">71.00</td>
          <td align="center" valign="top" charoff="50">70.89</td>
          <td align="center" valign="top" charoff="50">71.41</td>
          <td align="center" valign="top" charoff="50">35.50</td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">Crysalis II</td>
          <td align="center" valign="top" charoff="50">
            <bold>0.838</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>0.435</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>76.27</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>76.28</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>76.20</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>42.84</bold>
          </td>
        </tr>
      </tbody>
    </table>
    <table-wrap-foot>
      <fn id="t3-fn1">
        <p>Performance was evaluated using independent test datasets. Note that most methods (ParCrys, OBScore, CRYSTAP2, XtalPred, and SVMCRYs) only provide one-class prediction (CRYs) and PPCPred includes four-class (MF, PF, CF, and CRYs) predictors. Thus, we only compared the performance of these tools for valid classes. In the case of PredPPCrys, we compared its performance with Crysalis for all five classes.</p>
      </fn>
    </table-wrap-foot>
  </table-wrap>
  <table-wrap position="float" id="t4">
    <label>Table 4</label>
    <caption>
      <title>Statistical analysis of site non-optimality for protein crystallizability engineering using the independent test dataset for the CRYs class (sequence redundancy removed at 25% sequence identity).</title>
    </caption>
    <table frame="hsides" rules="groups" border="1">
      <colgroup>
        <col align="left"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
      </colgroup>
      <thead valign="bottom">
        <tr>
          <th rowspan="2" align="left" valign="top" charoff="50"><italic>C</italic><sub><italic>i</italic></sub> threshold</th>
          <th rowspan="2" align="center" valign="top" charoff="50">All<xref ref-type="fn" rid="t4-fn1">a</xref>(645599)</th>
          <th colspan="3" align="center" valign="top" charoff="50">Secondary structure<hr/></th>
          <th colspan="2" align="center" valign="top" charoff="50">Disorder<hr/></th>
          <th colspan="2" align="center" valign="top" charoff="50">Buried/Exposed<hr/></th>
          <th colspan="3" align="center" valign="top" charoff="50">Side chain entropy<xref ref-type="fn" rid="t4-fn2">b</xref><hr/></th>
        </tr>
        <tr>
          <th align="center" valign="top" charoff="50">Coil(296571)</th>
          <th align="center" valign="top" charoff="50">Helix(260752)</th>
          <th align="center" valign="top" charoff="50">Sheet(88276)</th>
          <th align="center" valign="top" charoff="50">Disorder(66129)</th>
          <th align="center" valign="top" charoff="50">Order(536962)</th>
          <th align="center" valign="top" charoff="50">Exposed(275189)</th>
          <th align="center" valign="top" charoff="50">Buried(370410)</th>
          <th align="center" valign="top" charoff="50">SCE(96423)</th>
          <th align="center" valign="top" charoff="50">SCE_E(74506)</th>
          <th align="center" valign="top" charoff="50">SCE_B(21917)</th>
        </tr>
      </thead>
      <tbody valign="top">
        <tr>
          <td align="left" valign="top" charoff="50"><italic>C</italic><sub><italic>i</italic></sub> &gt; 0.005</td>
          <td align="center" valign="top" charoff="50">52.2%</td>
          <td align="center" valign="top" charoff="50">49.8%</td>
          <td align="center" valign="top" charoff="50">56.1%</td>
          <td align="center" valign="top" charoff="50">49.1%</td>
          <td align="center" valign="top" charoff="50">57.3%</td>
          <td align="center" valign="top" charoff="50">52.3%</td>
          <td align="center" valign="top" charoff="50">51.1%</td>
          <td align="center" valign="top" charoff="50">53.2%</td>
          <td align="center" valign="top" charoff="50">36.3%</td>
          <td align="center" valign="top" charoff="50">38.0%</td>
          <td align="center" valign="top" charoff="50">30.4%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50"><italic>C</italic><sub><italic>i</italic></sub> &gt; 0.010</td>
          <td align="center" valign="top" charoff="50">32.3%</td>
          <td align="center" valign="top" charoff="50">30.2%</td>
          <td align="center" valign="top" charoff="50">35.4%</td>
          <td align="center" valign="top" charoff="50">29.8%</td>
          <td align="center" valign="top" charoff="50">39.3%</td>
          <td align="center" valign="top" charoff="50">32.2%</td>
          <td align="center" valign="top" charoff="50">31.7%</td>
          <td align="center" valign="top" charoff="50">32.7%</td>
          <td align="center" valign="top" charoff="50">21.4%</td>
          <td align="center" valign="top" charoff="50">22.9%</td>
          <td align="center" valign="top" charoff="50">16.3%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50"><italic>C</italic><sub><italic>i</italic></sub> &gt; 0.02</td>
          <td align="center" valign="top" charoff="50">15.3%</td>
          <td align="center" valign="top" charoff="50">14.2%</td>
          <td align="center" valign="top" charoff="50">16.9%</td>
          <td align="center" valign="top" charoff="50">14.6%</td>
          <td align="center" valign="top" charoff="50">22.7%</td>
          <td align="center" valign="top" charoff="50">15.1%</td>
          <td align="center" valign="top" charoff="50">15.9%</td>
          <td align="center" valign="top" charoff="50">15.0%</td>
          <td align="center" valign="top" charoff="50">10.6%</td>
          <td align="center" valign="top" charoff="50">11.6%</td>
          <td align="center" valign="top" charoff="50">7.01%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50"><italic>C</italic><sub><italic>i</italic></sub> &gt; 0.05</td>
          <td align="center" valign="top" charoff="50">4.08%</td>
          <td align="center" valign="top" charoff="50">3.92%</td>
          <td align="center" valign="top" charoff="50">4.36%</td>
          <td align="center" valign="top" charoff="50">3.83%</td>
          <td align="center" valign="top" charoff="50">8.80%</td>
          <td align="center" valign="top" charoff="50">3.76%</td>
          <td align="center" valign="top" charoff="50">4.65%</td>
          <td align="center" valign="top" charoff="50">3.67%</td>
          <td align="center" valign="top" charoff="50">3.37%</td>
          <td align="center" valign="top" charoff="50">3.80%</td>
          <td align="center" valign="top" charoff="50">1.90%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50"><italic>C</italic><sub><italic>i</italic></sub> &gt; 0.1</td>
          <td align="center" valign="top" charoff="50">1.22%</td>
          <td align="center" valign="top" charoff="50">1.27%</td>
          <td align="center" valign="top" charoff="50">1.23%</td>
          <td align="center" valign="top" charoff="50">1.02%</td>
          <td align="center" valign="top" charoff="50">3.83%</td>
          <td align="center" valign="top" charoff="50">0.99%</td>
          <td align="center" valign="top" charoff="50">1.53%</td>
          <td align="center" valign="top" charoff="50">0.99%</td>
          <td align="center" valign="top" charoff="50">1.26%</td>
          <td align="center" valign="top" charoff="50">1.44%</td>
          <td align="center" valign="top" charoff="50">0.62%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50"><italic>C</italic><sub><italic>i</italic></sub> &gt; 0.2</td>
          <td align="center" valign="top" charoff="50">0.33%</td>
          <td align="center" valign="top" charoff="50">0.41%</td>
          <td align="center" valign="top" charoff="50">0.27%</td>
          <td align="center" valign="top" charoff="50">0.22%</td>
          <td align="center" valign="top" charoff="50">1.64%</td>
          <td align="center" valign="top" charoff="50">0.19%</td>
          <td align="center" valign="top" charoff="50">0.46%</td>
          <td align="center" valign="top" charoff="50">0.23%</td>
          <td align="center" valign="top" charoff="50">0.43%</td>
          <td align="center" valign="top" charoff="50">0.48%</td>
          <td align="center" valign="top" charoff="50">0.24%</td>
        </tr>
        <tr>
          <td colspan="3" align="center" valign="top" charoff="50">
            <bold>Charged Amino acids</bold>
          </td>
          <td colspan="3" align="center" valign="top" charoff="50">
            <bold>Hydrophobic</bold>
          </td>
          <td colspan="6" align="center" valign="top" charoff="50">
            <bold>Sequence loci</bold>
            <xref ref-type="fn" rid="t4-fn3">c</xref>
          </td>
        </tr>
        <tr>
          <td align="center" valign="top" charoff="50">
            <bold>Negative</bold>
            <bold>(73537)</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>Positive</bold>
            <bold>(83209)</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>Charged</bold>
            <bold>(156745)</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>Low</bold>
            <bold>(196812)</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>Middle</bold>
            <bold>(164236)</bold>
          </td>
          <td align="center" valign="top" charoff="50">
            <bold>High</bold>
            <bold>(284551)</bold>
          </td>
          <td colspan="2" align="center" valign="top" charoff="50">
            <bold>N-terminal (36180)</bold>
          </td>
          <td colspan="2" align="center" valign="top" charoff="50">
            <bold>Intermediate</bold>
            <bold>(573239)</bold>
          </td>
          <td colspan="2" align="center" valign="top" charoff="50">
            <bold>C-terminal</bold>
            <bold>(36180)</bold>
          </td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">35.4%</td>
          <td align="center" valign="top" charoff="50">55.4%</td>
          <td align="center" valign="top" charoff="50">46.0%</td>
          <td align="center" valign="top" charoff="50">49.6%</td>
          <td align="center" valign="top" charoff="50">51.7%</td>
          <td align="center" valign="top" charoff="50">54.3%</td>
          <td colspan="2" align="center" valign="top" charoff="50">67.5%</td>
          <td colspan="2" align="center" valign="top" charoff="50">50.6%</td>
          <td colspan="2" align="center" valign="top" charoff="50">62.3%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">22.7%</td>
          <td align="center" valign="top" charoff="50">36.0%</td>
          <td align="center" valign="top" charoff="50">29.7%</td>
          <td align="center" valign="top" charoff="50">31.2%</td>
          <td align="center" valign="top" charoff="50">30.3%</td>
          <td align="center" valign="top" charoff="50">34.1%</td>
          <td colspan="2" align="center" valign="top" charoff="50">48.9%</td>
          <td colspan="2" align="center" valign="top" charoff="50">30.4%</td>
          <td colspan="2" align="center" valign="top" charoff="50">45.6%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">12.4%</td>
          <td align="center" valign="top" charoff="50">19.0%</td>
          <td align="center" valign="top" charoff="50">15.9%</td>
          <td align="center" valign="top" charoff="50">15.7%</td>
          <td align="center" valign="top" charoff="50">13.9%</td>
          <td align="center" valign="top" charoff="50">16.0%</td>
          <td colspan="2" align="center" valign="top" charoff="50">29.3%</td>
          <td colspan="2" align="center" valign="top" charoff="50">13.7%</td>
          <td colspan="2" align="center" valign="top" charoff="50">28.1%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">4.45%</td>
          <td align="center" valign="top" charoff="50">6.01%</td>
          <td align="center" valign="top" charoff="50">5.28%</td>
          <td align="center" valign="top" charoff="50">4.42%</td>
          <td align="center" valign="top" charoff="50">3.81%</td>
          <td align="center" valign="top" charoff="50">4.01%</td>
          <td colspan="2" align="center" valign="top" charoff="50">10.8%</td>
          <td colspan="2" align="center" valign="top" charoff="50">3.18%</td>
          <td colspan="2" align="center" valign="top" charoff="50">11.8%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">1.62%</td>
          <td align="center" valign="top" charoff="50">2.35%</td>
          <td align="center" valign="top" charoff="50">2.00%</td>
          <td align="center" valign="top" charoff="50">1.35%</td>
          <td align="center" valign="top" charoff="50">1.30%</td>
          <td align="center" valign="top" charoff="50">1.08%</td>
          <td colspan="2" align="center" valign="top" charoff="50">3.76%</td>
          <td colspan="2" align="center" valign="top" charoff="50">0.78%</td>
          <td colspan="2" align="center" valign="top" charoff="50">5.66%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">0.56%</td>
          <td align="center" valign="top" charoff="50">0.95%</td>
          <td align="center" valign="top" charoff="50">0.77%</td>
          <td align="center" valign="top" charoff="50">0.36%</td>
          <td align="center" valign="top" charoff="50">0.47%</td>
          <td align="center" valign="top" charoff="50">0.23%</td>
          <td colspan="2" align="center" valign="top" charoff="50">0.90%</td>
          <td colspan="2" align="center" valign="top" charoff="50">0.14%</td>
          <td colspan="2" align="center" valign="top" charoff="50">2.75%</td>
        </tr>
      </tbody>
    </table>
    <table-wrap-foot>
      <fn id="t4-fn1">
        <p><sup>a</sup>The dataset contains 2,342 proteins comprising of 1,814 proteins currently classified as non-crystallizable. Residue numbers for different groups are shown in brackets.</p>
      </fn>
      <fn id="t4-fn2">
        <p><sup>b</sup>Statistical analysis of side-chain entropy considered three residues with high conformational entropies (KQE). SCE denotes the number of KQE residues in the entire sequence, while SCE_E and SCE_B denote the numbers of KQE residues annotated to be localized to exposed or buried regions, respectively.</p>
      </fn>
      <fn id="t4-fn3">
        <p><sup>c</sup>N-terminal and C-terminal denote the initial and final 20 residues located at the N- or C-terminal region of protein sequences. The Intermediate group is comprised of all residues from protein sequences, excluding N-terminal and C-terminal residues.</p>
      </fn>
    </table-wrap-foot>
  </table-wrap>
  <table-wrap position="float" id="t5">
    <label>Table 5</label>
    <caption>
      <title>Site non-optimality analysis of 20 standard amino acids for protein crystallizability.</title>
    </caption>
    <table frame="hsides" rules="groups" border="1">
      <colgroup>
        <col align="left"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
      </colgroup>
      <thead valign="bottom">
        <tr>
          <th rowspan="2" align="left" valign="top" charoff="50">AAs</th>
          <th rowspan="2" align="center" valign="top" charoff="50">Number</th>
          <th colspan="6" align="center" valign="top" charoff="50"><italic>C</italic><sub>i</sub> threshold of site nonoptimality<hr/></th>
        </tr>
        <tr>
          <th align="center" valign="top" charoff="50">0.005</th>
          <th align="center" valign="top" charoff="50">0.01</th>
          <th align="center" valign="top" charoff="50">0.02</th>
          <th align="center" valign="top" charoff="50">0.05</th>
          <th align="center" valign="top" charoff="50">0.1</th>
          <th align="center" valign="top" charoff="50">0.2</th>
        </tr>
      </thead>
      <tbody valign="top">
        <tr>
          <td align="left" valign="top" charoff="50">Total</td>
          <td align="center" valign="top" charoff="50">645599</td>
          <td align="center" valign="top" charoff="50">52.2%</td>
          <td align="center" valign="top" charoff="50">32.2%</td>
          <td align="center" valign="top" charoff="50">15.3%</td>
          <td align="center" valign="top" charoff="50">4.08%</td>
          <td align="center" valign="top" charoff="50">1.22%</td>
          <td align="center" valign="top" charoff="50">0.33%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">A</td>
          <td align="center" valign="top" charoff="50">57068</td>
          <td align="center" valign="top" charoff="50">53.8%</td>
          <td align="center" valign="top" charoff="50">27.4%</td>
          <td align="center" valign="top" charoff="50">9.68%</td>
          <td align="center" valign="top" charoff="50">1.54%</td>
          <td align="center" valign="top" charoff="50">0.24%</td>
          <td align="center" valign="top" charoff="50">0.21%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">C</td>
          <td align="center" valign="top" charoff="50">8137</td>
          <td align="center" valign="top" charoff="50">85.7%</td>
          <td align="center" valign="top" charoff="50">73.8%</td>
          <td align="center" valign="top" charoff="50">45.9%</td>
          <td align="center" valign="top" charoff="50">16.1%</td>
          <td align="center" valign="top" charoff="50">4.48%</td>
          <td align="center" valign="top" charoff="50">0.96%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">D</td>
          <td align="center" valign="top" charoff="50">34265</td>
          <td align="center" valign="top" charoff="50">46.9%</td>
          <td align="center" valign="top" charoff="50">29.7%</td>
          <td align="center" valign="top" charoff="50">15.7%</td>
          <td align="center" valign="top" charoff="50">5.05%</td>
          <td align="center" valign="top" charoff="50">1.48%</td>
          <td align="center" valign="top" charoff="50">0.34%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">E</td>
          <td align="center" valign="top" charoff="50">39524</td>
          <td align="center" valign="top" charoff="50">25.5%</td>
          <td align="center" valign="top" charoff="50">16.6%</td>
          <td align="center" valign="top" charoff="50">9.55%</td>
          <td align="center" valign="top" charoff="50">3.94%</td>
          <td align="center" valign="top" charoff="50">1.73%</td>
          <td align="center" valign="top" charoff="50">0.75%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">F</td>
          <td align="center" valign="top" charoff="50">27004</td>
          <td align="center" valign="top" charoff="50">59.1%</td>
          <td align="center" valign="top" charoff="50">42.3%</td>
          <td align="center" valign="top" charoff="50">24.3%</td>
          <td align="center" valign="top" charoff="50">6.65%</td>
          <td align="center" valign="top" charoff="50">2.00%</td>
          <td align="center" valign="top" charoff="50">0.42%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">G</td>
          <td align="center" valign="top" charoff="50">45831</td>
          <td align="center" valign="top" charoff="50">36.9%</td>
          <td align="center" valign="top" charoff="50">18.0%</td>
          <td align="center" valign="top" charoff="50">6.12%</td>
          <td align="center" valign="top" charoff="50">1.23%</td>
          <td align="center" valign="top" charoff="50">0.32%</td>
          <td align="center" valign="top" charoff="50">0.08%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">H</td>
          <td align="center" valign="top" charoff="50">14891</td>
          <td align="center" valign="top" charoff="50">50.2%</td>
          <td align="center" valign="top" charoff="50">38.5%</td>
          <td align="center" valign="top" charoff="50">26.2%</td>
          <td align="center" valign="top" charoff="50">12.9%</td>
          <td align="center" valign="top" charoff="50">7.20%</td>
          <td align="center" valign="top" charoff="50">4.02%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">I</td>
          <td align="center" valign="top" charoff="50">36964</td>
          <td align="center" valign="top" charoff="50">53.7%</td>
          <td align="center" valign="top" charoff="50">35.5%</td>
          <td align="center" valign="top" charoff="50">17.0%</td>
          <td align="center" valign="top" charoff="50">4.05%</td>
          <td align="center" valign="top" charoff="50">1.02%</td>
          <td align="center" valign="top" charoff="50">0.16%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">K</td>
          <td align="center" valign="top" charoff="50">32967</td>
          <td align="center" valign="top" charoff="50">37.0%</td>
          <td align="center" valign="top" charoff="50">20.2%</td>
          <td align="center" valign="top" charoff="50">9.45%</td>
          <td align="center" valign="top" charoff="50">2.77%</td>
          <td align="center" valign="top" charoff="50">1.00%</td>
          <td align="center" valign="top" charoff="50">0.27%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">L</td>
          <td align="center" valign="top" charoff="50">68034</td>
          <td align="center" valign="top" charoff="50">59.1%</td>
          <td align="center" valign="top" charoff="50">40.2%</td>
          <td align="center" valign="top" charoff="50">20.3%</td>
          <td align="center" valign="top" charoff="50">5.88%</td>
          <td align="center" valign="top" charoff="50">1.81%</td>
          <td align="center" valign="top" charoff="50">0.51%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">M</td>
          <td align="center" valign="top" charoff="50">14613</td>
          <td align="center" valign="top" charoff="50">56.3%</td>
          <td align="center" valign="top" charoff="50">34.7%</td>
          <td align="center" valign="top" charoff="50">15.6%</td>
          <td align="center" valign="top" charoff="50">3.60%</td>
          <td align="center" valign="top" charoff="50">0.82%</td>
          <td align="center" valign="top" charoff="50">0.07%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">N</td>
          <td align="center" valign="top" charoff="50">25557</td>
          <td align="center" valign="top" charoff="50">76.7%</td>
          <td align="center" valign="top" charoff="50">53.1%</td>
          <td align="center" valign="top" charoff="50">27.6%</td>
          <td align="center" valign="top" charoff="50">7.09%</td>
          <td align="center" valign="top" charoff="50">1.86%</td>
          <td align="center" valign="top" charoff="50">0.33%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">P</td>
          <td align="center" valign="top" charoff="50">29532</td>
          <td align="center" valign="top" charoff="50">45.5%</td>
          <td align="center" valign="top" charoff="50">23.6%</td>
          <td align="center" valign="top" charoff="50">9.33%</td>
          <td align="center" valign="top" charoff="50">1.81%</td>
          <td align="center" valign="top" charoff="50">0.38%</td>
          <td align="center" valign="top" charoff="50">0.04%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">Q</td>
          <td align="center" valign="top" charoff="50">24284</td>
          <td align="center" valign="top" charoff="50">53.0%</td>
          <td align="center" valign="top" charoff="50">30.8%</td>
          <td align="center" valign="top" charoff="50">13.8%</td>
          <td align="center" valign="top" charoff="50">3.25%</td>
          <td align="center" valign="top" charoff="50">0.82%</td>
          <td align="center" valign="top" charoff="50">0.11%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">R</td>
          <td align="center" valign="top" charoff="50">35632</td>
          <td align="center" valign="top" charoff="50">74.6%</td>
          <td align="center" valign="top" charoff="50">49.5%</td>
          <td align="center" valign="top" charoff="50">24.9%</td>
          <td align="center" valign="top" charoff="50">6.13%</td>
          <td align="center" valign="top" charoff="50">1.55%</td>
          <td align="center" valign="top" charoff="50">0.29%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">S</td>
          <td align="center" valign="top" charoff="50">44801</td>
          <td align="center" valign="top" charoff="50">72.5%</td>
          <td align="center" valign="top" charoff="50">45.5%</td>
          <td align="center" valign="top" charoff="50">22.0%</td>
          <td align="center" valign="top" charoff="50">5.34%</td>
          <td align="center" valign="top" charoff="50">1.38%</td>
          <td align="center" valign="top" charoff="50">0.23%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">T</td>
          <td align="center" valign="top" charoff="50">35036</td>
          <td align="center" valign="top" charoff="50">44.4%</td>
          <td align="center" valign="top" charoff="50">23.4%</td>
          <td align="center" valign="top" charoff="50">8.66%</td>
          <td align="center" valign="top" charoff="50">1.78%</td>
          <td align="center" valign="top" charoff="50">0.33%</td>
          <td align="center" valign="top" charoff="50">0.03%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">V</td>
          <td align="center" valign="top" charoff="50">43817</td>
          <td align="center" valign="top" charoff="50">46.2%</td>
          <td align="center" valign="top" charoff="50">25.9%</td>
          <td align="center" valign="top" charoff="50">10.1%</td>
          <td align="center" valign="top" charoff="50">1.95%</td>
          <td align="center" valign="top" charoff="50">0.49%</td>
          <td align="center" valign="top" charoff="50">0.06%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">W</td>
          <td align="center" valign="top" charoff="50">9114</td>
          <td align="center" valign="top" charoff="50">37.0%</td>
          <td align="center" valign="top" charoff="50">23.2%</td>
          <td align="center" valign="top" charoff="50">10.4%</td>
          <td align="center" valign="top" charoff="50">2.40%</td>
          <td align="center" valign="top" charoff="50">0.51%</td>
          <td align="center" valign="top" charoff="50">0.08%</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">Y</td>
          <td align="center" valign="top" charoff="50">20786</td>
          <td align="center" valign="top" charoff="50">46.0%</td>
          <td align="center" valign="top" charoff="50">25.5%</td>
          <td align="center" valign="top" charoff="50">9.64%</td>
          <td align="center" valign="top" charoff="50">1.76%</td>
          <td align="center" valign="top" charoff="50">0.33%</td>
          <td align="center" valign="top" charoff="50">0.01%</td>
        </tr>
      </tbody>
    </table>
    <table-wrap-foot>
      <fn id="t5-fn1">
        <p>Crysalis performed the computational design of the CRYs class using proteins currently classified as non-crystallizable in the independent test datasets with 25% sequence identity.</p>
      </fn>
    </table-wrap-foot>
  </table-wrap>
  <table-wrap position="float" id="t6">
    <label>Table 6</label>
    <caption>
      <title>Classification of the 20 amino acids in the GKSAAP encoding scheme according to six different types of physicochemical properties.</title>
    </caption>
    <table frame="hsides" rules="groups" border="1">
      <colgroup>
        <col align="left"/>
        <col align="center"/>
        <col align="center"/>
        <col align="center"/>
      </colgroup>
      <thead valign="bottom">
        <tr>
          <th align="left" valign="top" charoff="50">Physicochemical property</th>
          <th align="center" valign="top" charoff="50">Low</th>
          <th align="center" valign="top" charoff="50">Middle</th>
          <th align="center" valign="top" charoff="50">High</th>
        </tr>
      </thead>
      <tbody valign="top">
        <tr>
          <td align="left" valign="top" charoff="50">Accessible surface area</td>
          <td align="center" valign="top" charoff="50">ACGILFV</td>
          <td align="center" valign="top" charoff="50">HMPSTWY</td>
          <td align="center" valign="top" charoff="50">RNDQEK</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">Side-chain orientation</td>
          <td align="center" valign="top" charoff="50">NDQEK</td>
          <td align="center" valign="top" charoff="50">ARGHPSTWYV</td>
          <td align="center" valign="top" charoff="50">CILMF</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">Charge</td>
          <td align="center" valign="top" charoff="50">DE</td>
          <td align="center" valign="top" charoff="50">NQCILMFSWTYVAGP</td>
          <td align="center" valign="top" charoff="50">KHR</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">Hydrogen-bond donors</td>
          <td align="center" valign="top" charoff="50">ADCGST</td>
          <td align="center" valign="top" charoff="50">NQEHILMPV</td>
          <td align="center" valign="top" charoff="50">RKFWY</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">Hydrophobicity</td>
          <td align="center" valign="top" charoff="50">THGSQ</td>
          <td align="center" valign="top" charoff="50">RKNDEP</td>
          <td align="center" valign="top" charoff="50">FIWLVMYCA</td>
        </tr>
        <tr>
          <td align="left" valign="top" charoff="50">van der Waals potential</td>
          <td align="center" valign="top" charoff="50">ILMFWY</td>
          <td align="center" valign="top" charoff="50">RCQEHKPV</td>
          <td align="center" valign="top" charoff="50">ANDGST</td>
        </tr>
      </tbody>
    </table>
  </table-wrap>
</floats-group>
